WO2008038721A1 - Ocular lens - Google Patents

Ocular lens Download PDF

Info

Publication number
WO2008038721A1
WO2008038721A1 PCT/JP2007/068831 JP2007068831W WO2008038721A1 WO 2008038721 A1 WO2008038721 A1 WO 2008038721A1 JP 2007068831 W JP2007068831 W JP 2007068831W WO 2008038721 A1 WO2008038721 A1 WO 2008038721A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
ophthalmic lens
silicone
monomer
lens according
Prior art date
Application number
PCT/JP2007/068831
Other languages
French (fr)
Japanese (ja)
Inventor
Kazuhiko Fujisawa
Tsutomu Goshima
Masataka Nakamura
Original Assignee
Toray Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries, Inc. filed Critical Toray Industries, Inc.
Publication of WO2008038721A1 publication Critical patent/WO2008038721A1/en

Links

Classifications

    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041Lenses
    • G02B1/043Contact lenses

Definitions

  • the present invention relates to an ophthalmic lens, and the ophthalmic lens is particularly preferably used for a contact lens, an intraocular lens, an artificial cornea, and the like.
  • the present invention has the following configuration. That is,
  • An ophthalmic lens comprising: a polymer compound (A) having a monomer unit having an ammoium group in the molecule, dispersed in a gel or gel (B).
  • Polar basic force S hydroxyl group, amide group, carboxyl group, amino group, carbonate group, carbamate group, sulfonamide group, sulfonic acid group, phosphonic acid group of the polar silicone component
  • the ophthalmic lens as described in (4) above which is a group selected from the group consisting of methoxyethyl group, methoxyethoxyethyl group, hydroxyethyl group, and hydroxyethoxyethyl group.
  • At least one of the silicone components is represented by the following general formula (a)
  • the ophthalmic lens according to any one of (3) to (5) above which has a structure obtained from a silicone monomer represented by
  • M represents a polymerizable group capable of radical polymerization.
  • L represents an optionally substituted divalent organic group having 1 to 20 carbon atoms.
  • A represents a siloxanyl group.
  • At least one of the silicone monomers is represented by the following formulas (d), (e) and (g) [0007] [Chemical Formula 2]
  • the ophthalmic lens as described in (6) above which is a monomer selected from the group consisting of force and the like.
  • R 1 represents an optionally substituted alkyl group having 1 to 30 carbon atoms.
  • R 2 to R 7 are substituted with 1 to 20 carbon atoms! /, May! /, Alkyl groups or carbon atoms.
  • X— represents any anion.
  • the ophthalmic lens of the present invention is obtained by dispersing a polymer compound having an ammonium group in a molecule in a hyde mouth gel which is a hydrophilic polymer having a network structure.
  • a polymer compound having an ammonium group in a molecule in a hyde mouth gel which is a hydrophilic polymer having a network structure.
  • that the polymer compound is dispersed in the hyde mouth gel does not include the case where the polymer compound is simply attached to the hyde mouth gel surface, and the ophthalmic lens surface is cleaned by ultrasonic cleaning using water. After washing, when the polymer compound contained in the ophthalmic lens is extracted with an organic solvent, the polymer compound having an ammonium group in the molecule is extracted.
  • a polymer compound having an ammonium group in the molecule is extracted by the extraction operation, it is determined that the polymer compound is dispersed in the gel. Specifically, extraction is performed using methanol, ethanol, 2-propanol, toluene, hexane, acetone, methyl ethyl ketone, ethyl acetate, butyl acetate, tetrahydrofuran, dimethyl sulfoxide as an organic solvent, and at least one of these is used.
  • a polymer compound having an ammonium group in the molecule is extracted by 0.1% or more of the dry weight of the hide-mouthed gel, it is determined that the polymer compound is dispersed.
  • the hydrophilic monomer used in the hide-mouthed gel (B) of the ophthalmic lens of the present invention is not particularly limited as long as it can be polymerized.
  • (Meth) Atalyloyl group, styryl group, allyl group, bulle Monomers having other groups and other polymerizable carbon-carbon unsaturated bonds can be used.
  • the hydrogel is preferably a silicone hydride gel further containing a silicone component. If the content of the silicone component in the silicone hydride gel is small, the oxygen permeability necessary for continuous use of the ophthalmic lens cannot be obtained, and if it is large, the compatibility with the hydrophilic component is difficult to obtain. Therefore, when the total weight of various monomers is 100 parts by weight, the content of the silicone monomer is preferably 20 to 80 parts by weight, more preferably 30 to 80 parts by weight, and most preferably 50 to 80 parts by weight. ! /
  • the hyde mouth gel (B) of the ophthalmic lens of the present invention is a silicone hyde mouth gel, a polymer compound having a hydrophobic silicone component and a monomer unit having a hydrophilic ammonium group (In order to obtain sufficient compatibility with (A), it is preferable that 30% or more of the number of key atoms in the silicone component is a key atom in the polar silicone component, and more than 40% is more. 50% or more is most preferable.
  • the polar silicone component represents a structure obtained by polymerizing a polar silicone monomer having a polar group in the molecule.
  • polar groups include hydroxyl groups, amide groups, carboxynole groups, amino groups, carbonate groups, carbamate groups, sulfonamide groups, sulfonic acid groups, phosphonic acid groups, methoxyethyl groups, methoxyethoxyethyl groups, hydroxyethyl groups. Group, hydroxyethoxyethyl group and the like.
  • the ophthalmic lens of the present invention is a silicone nodule gel
  • a hydroxyl group such as 2-hydroxyethyl (meth) acrylate is particularly used as a hydrophilic monomer. It is preferred to copolymerize (meth) acrylate monomers that have! use If the amount used is too small, the effect of improving transparency cannot be obtained. If too much is used, the physical properties of the polymer will be affected, so 0.;! ⁇ 25 parts by weight is preferred 0.5 to 20 parts by weight Parts are more preferred, 1.0-- 15 parts by weight is most preferred.
  • the number of hydroxyl groups in the ophthalmic lens is OH and the number of ammonium nitrogen is N, if the N / OH ratio is too small, sufficient antibacterial properties cannot be obtained, and if it is too large, the ophthalmic lens has sufficient transparency. In this case, 0.001 to 0.5 is preferable, 0.005 to 0.4 is more preferable, 0.0;! To 0.3 is also preferable.
  • the method for measuring the N / OH ratio is selected according to the type and amount of each component in the hide-mouth gel and the antibacterial polymer, and examples thereof include nuclear magnetic resonance (NMR) and infrared spectroscopy.
  • IR IR
  • ATR total reflection infrared absorption measurement
  • UV ultraviolet spectroscopy
  • Examples of the polymerization method of the silicone hydride gel used in the ophthalmic lens of the present invention include a method obtained by polymerizing a mixture of various monomers such as a silicone monomer, a hydrophilic monomer, and a crosslinking monomer, a silicone monomer, a hydrophilic monomer, and the like. Examples include a method in which various monomers are homopolymerized or copolymerized, and then a macromonomer having a polymerizable group introduced is polymerized.
  • the silicone monomer obtained by polymerizing the silicone hydride gel of the present invention from a monomer functions as a cross-linking agent when it has two or more polymerizable groups, and the resulting elastic modulus of the silicone nodulogel Is too high, the following general formula (a)
  • a silicone monomer having a structure having one polymerizable group in the molecule is preferred! /.
  • represents a polymerizable group capable of radical polymerization.
  • the polymerizable group capable of radical polymerization include vinylene group, vinylol group, vinyloxy group, aryloxy group, bull force rubamate group, aryl carbamate group, bull carbonate group, aryl carbonate group, metatalolyl group, allyloyl group, styryl group. Groups and the like.
  • the attalyloyl group and the methacryloyl group are preferable from the viewpoint of the elastic modulus of the obtained polymer.
  • L represents an optionally substituted divalent organic group having carbon number;
  • an alkylene group is more preferable.
  • Divalent hydrocarbon groups such as tilethylene, n-propylene, n-butylene, 2-methylpropylene, 2,2-dimethylpropylene, n-pentylene, 2-hydroxypropylene, 2-hydroxybutylene, 3
  • a divalent organic group having a hydroxyl group such as a hydroxybutylene group, a divalent organic group having an ether bond as represented by the following formulas (L1 ;!) to (L3), and the following formula ( Examples thereof include divalent organic groups having both an ether bond and a hydroxyl group represented by formulas such as L 4) and (L 5).
  • M is most preferably 1-5.
  • Sx represents a siloxanyl group.
  • the siloxanyl group represents a group having at least one Si—O—Si bond in the structure.
  • the silicone monomer represented by the general formula (a) is preferably the one represented by the following general formula (a ').
  • n represents an integer of 0 to 200.
  • a, b and c each independently represents an integer of 0 to 20.
  • n + a + b + c represents the number of siloxane bonds in the silicone compound. If the number of n + a + b + c is too small, the oxygen permeability required for ophthalmic lenses and contact lenses will be sufficient. If the amount is too large, the compatibility with various hydrophilic monomers often used as a copolymerization component is reduced, and a transparent lens cannot be obtained. More preferably, 2 to 50 is most preferable.
  • Ai A 11 represents an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted aryl group having 6 to 20 carbon atoms. Substituent represented by the above structure Among them, the compound having such a substituent is industrially available at a relatively low cost.
  • silicone monomers represented by the general formula (a) those that are preferable in terms of compatibility with hydrophilic monomers and ammonium salt monomers, oxygen permeability of polymers obtained by polymerization, mechanical properties, and the like are preferable.
  • Q represents an alkyl group having 1 to 8 carbon atoms.
  • P represents an integer of 1 to 20.
  • a transparent silicone polymer can be easily obtained even when mixed with an internal wetting agent such as polybulurpyrrolidone, a silicone monomer having a hydroxyl group in the molecule as represented by formula (e) or formula (i). Is most preferred.
  • the macromonomer is a monomer having a molecular weight of 800 or more and having one or more polymerizable groups.
  • the silicone nodule gel used in the ophthalmic lens of the present invention is obtained from a macromonomer
  • the above-mentioned various silicone monomers are homopolymerized and then introduced with a polymerizable group to co-polymerize with various hydrophilic monomers and the like.
  • Polymerization method, various silicone monomers, various hydrophilic monomers And the like, and then polymerizing by introducing a polymerizable group is preferable because compatibility between the silicone component and the hydrophilic component is easily increased.
  • the molecular weight of the silicone macromonomer is too low, one of the advantages of using the macromonomer is that the effect of inhibiting polymerization shrinkage is not sufficient, and if the molecular weight is too high, the viscosity of the macromonomer becomes too high and handling becomes difficult. From the viewpoint of lowering the solubility in the polymerization solvent, 1000 to 1,000,000 S is preferable, 3000 to 500,000 S is more preferable, and 500 00 to 100,000 is most preferable.
  • the ammonium salt monomer constituting the polymer compound used in the ophthalmic lens of the present invention may be any monomer having a polymerizable group and an ammonium cation in the molecule.
  • the polymerizable group is not particularly limited as long as it can be radically polymerized.
  • Ataryloyl group (meth) acrylamido group, styryl group, allyl group, bur group, and other radically polymerizable carbon-carbon unsaturated bonds
  • ammonium cation may be independently substituted with three substituent groups other than one leading to a polymerizable group on the nitrogen atom, or may be substituted with an alkyl group having 1 to 20 carbon atoms or substituted! / Or, it is an aryl group having 6 to 20 carbon atoms, and these substituents may form a ring with each other. Examples of more specific structures are the following general formulas (f), (h), (i)
  • R 8 to R 1 () are each independently an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted carbon number 6 Represents an aryl group of ⁇ 20, R 11 represents hydrogen or a methyl group, Z represents O or NH, X— represents an arbitrary anion, and the like.
  • the burium imidazolium salt represented by the general formula (f) is most preferable in terms of heat stability and antibacterial properties.
  • R 1 represents an optionally substituted alkyl group having 1 to 30 carbon atoms. If the number of carbon atoms is small, the hydrophilicity of the ammonium cation moiety makes it compatible with the silicone monomer. When the number of carbon atoms is too low, the compatibility with hydrophilic monomers decreases, so 4 to 20 carbon atoms are more preferred! /.
  • R 2 to R 7 are optionally substituted alkyl groups having 1 to 20 carbon atoms or substituted with 6 to 20 carbon atoms! /, May! /, Aryl Represents a group.
  • R 2 may form a ring! / ⁇ .
  • X— represents an arbitrary anion.
  • examples thereof include halide ions such as fluoride ions, chloride ions, bromide ions, iodide ions, hydroxide ions, sulfate ions, nitrate ions, boron tetrafluoride ions, and the like. Of these, halide ions are most preferred from the viewpoint of ease of synthesis.
  • the polymer compound of the present invention may be a homopolymer of ammonium salt monomers or a copolymer with other monomers.
  • the total weight of the various monomers in the copolymer is 100 parts by weight, the content of the ammonium salt monomer is too small to obtain sufficient antibacterial properties. More than 30 parts by weight is most preferred!
  • Examples of the monomer in the case where the polymer compound used in the ophthalmic lens of the present invention is copolymerized with a monomer other than the ammonium salt monomer are not particularly limited as long as copolymerization is possible (meta-metabolism). ) Monomers having an allyloyl group, a styryl group, a allyl group, a bur group, and other polymerizable carbon'carbon unsaturated bonds can be used.
  • Examples include amide monomers such as N-Buylpyrrolidone, N, N-Dimethylacrylamide, N-Buylformamide, N-Bulucacetamide, 2-Hydroxyethyl methacrylate, and 2 (2-Hydroxyl).
  • Monomers having a hydroxyl group such as ethoxy) ethyl methacrylate, silicone monomers such as 3-tris (trimethylsiloxy) silylpropyl methacrylate, polydimethylsiloxane having a (meth) acryl group at one or both ends And so on.
  • an amide monomer and a monomer having a hydroxyl group are more preferable because they are easily compatible with an ammonium salt monomer, and N-vinylpyrrolidone is most preferable.
  • the molecular weight of the polymer compound used in the ophthalmic lens of the present invention is too small, the polymer compound is likely to elute the substrate, and if it is too large, the polymer compound monomer mixture or a liquid containing it is contained. Since the solubility with respect to the immersion solution is lowered, 1000 to 1 million, preferably S, more preferably 5,000 to 500,000, most preferably 10,000 to 300,000.
  • two or more copolymerizable carbons in one molecule are obtained in the sense that good mechanical properties are obtained and good resistance to a disinfecting solution and a cleaning solution is obtained. It is preferable to use a monomer having a carbon unsaturated bond as a copolymerization component.
  • the copolymerization ratio of two or more copolymerizable carbon-carbon unsaturated bonds in one molecule is preferably 0.;! To 20% by weight, preferably 0.3 to 15% by weight, more preferably 0 5 to 10% by weight is more preferable.
  • the ophthalmic lens of the present invention may contain an ultraviolet absorber, a pigment, a colorant, and the like! It may also contain UV-absorbers, dyes, and colorants having a polymerizable group in a copolymerized form! / ⁇
  • a thermal polymerization initiator typified by a peroxide or a azo compound or a photopolymerization initiator in order to facilitate polymerization.
  • thermal polymerization select one having the optimum decomposition characteristics for the desired reaction temperature.
  • azo initiators and peroxide initiators having a 10-hour half-life temperature of 40 ° C to 120 ° C are suitable.
  • the photopolymerization initiator include carbonyl compounds, peroxides, azo compounds, sulfur compounds, halogen compounds, and metal salts. These polymerization initiators are used alone or in combination, and are used in an amount of up to about 1% by weight.
  • a polymerization solvent can be used.
  • the solvent various organic and inorganic solvents are applicable and there is no particular limitation.
  • aromatic hydrocarbon solvents such as hexane, heptane, octane, decane, petroleum ether, kerosene, rig in, para
  • Various aliphatic hydrocarbon solvents such as fins, various ketone solvents such as acetone, methyl ethyl ketone and methyl isobutyl ketone, various ester systems such as ethyl acetate, butyl acetate, methyl be
  • the polymerization method and molding method for the ophthalmic lens of the present invention ordinary methods can be used. For example, a method of once forming a round bar or a plate and processing it into a desired shape by cutting or the like, a mold polymerization method, a spin cast method, or the like.
  • the ophthalmic lens of the present invention is obtained by the mold polymerization method will be described below.
  • the monomer composition is filled in the space between two molds having a certain shape. Then, photopolymerization or thermal polymerization is performed to shape the mold.
  • the mold is made of resin, glass, ceramics, metal, etc., but in the case of photopolymerization, an optically transparent material is used, and usually resin or glass is used.
  • a polymer is produced, in many cases, a void is formed by two opposing molds, and the force S that fills the void with the monomer composition S, and depending on the shape of the mold and the properties of the monomer, A gasket having the purpose of giving a constant thickness and preventing leakage of the filled monomer composition may be used in combination.
  • the mold in which the voids are filled with the monomer composition is heated by being put in an oven or a liquid bath with the power to be irradiated with an actinic ray such as ultraviolet rays to polymerize the monomer.
  • an actinic ray such as ultraviolet rays to polymerize the monomer.
  • an actinic ray such as ultraviolet rays to polymerize the monomer.
  • both are used in combination, such as heat polymerization after photopolymerization or conversely photopolymerization after heat polymerization.
  • photopolymerization it is common to irradiate light containing a large amount of ultraviolet light using a mercury lamp or insect trap as a light source for a short time (usually 1 hour or less).
  • the high molecular compound is dispersed in the network structure of the base hydrated gel.
  • a method of dispersing a polymer compound in a base material a method of polymerizing a hide-mouth gel in a state where a polymer compound is mixed in a raw monomer or raw material macromonomer mixture of a hide-mouth gel, Examples include a method of impregnating by impregnating in a solution of a molecular compound.
  • various organic and inorganic solvents can be applied to the polymer compound solution, and there is no particular limitation.
  • examples include water, methanol, ethanol, propanol, 2-propanol monoole, butanol, tert-butanol, tert-amyl alcohol, various alcohol solvents such as 3,7-dimethyl-3-octanol, benzene, toluene, xylene, etc.
  • concentration of the aqueous solution of the polymer compound is too low, sufficient antibacterial properties cannot be obtained, and if it is too high, it may be necessary to wash the excess polymer compound. 30% preferred 0.5 to 20% is more preferred;! To 10% is most preferred.
  • the ophthalmic lens of the present invention can be modified by various methods. It is preferable to perform a modification treatment that improves the wettability of the surface.
  • Specific reforming methods include electromagnetic wave (including light) irradiation, plasma irradiation, chemical vapor deposition treatment such as vapor deposition and sputtering, heating, base treatment, acid treatment, and other suitable surfaces. Mention may be made of the use of treatment agents and combinations thereof. Among these reforming means, simple and preferred are base and acid treatments.
  • Examples of the base treatment or acid treatment include a method of contacting an ophthalmic lens with a basic or acidic solution, a method of contacting an ophthalmic lens with a basic or acidic gas, and the like. More specific methods include, for example, a method in which an ophthalmic lens is immersed in a basic or acidic solution, a method in which a basic or acidic solution or basic or acidic gas is sprayed on an ophthalmic lens, or an ophthalmic lens. For example, a method of applying a basic or acidic solution with a spatula, a brush or the like, and applying a basic or acidic solution to an ophthalmic lens by a spin coating method or a dip coating method can be cited. The most simple method for obtaining a great modification effect is a method of immersing an ophthalmic lens in a basic or acidic solution.
  • the temperature at which the ophthalmic lens is immersed in a basic or acidic solution is not particularly limited, but is usually within a temperature range of about 50 ° C to 300 ° C. Considering workability, a temperature range of 10 ° C to 150 ° C is more preferable-5 ° C to 60 ° C is most preferable.
  • the time when the ophthalmic lens is immersed in a basic or acidic solution! / The force that changes the optimum time depending on the temperature Generally 0.;! ⁇ 100 hours are preferred 0.3 ⁇ 24 hours Is more preferable within 0.5; most preferably within 12 hours. If the contact time is too short, a sufficient treatment effect cannot be obtained, and if the contact time is too long, if workability and productivity are deteriorated, not only the power but also the oxygen permeability and mechanical properties are reduced. There may be adverse effects.
  • Examples of the base include alkali metal hydroxides, alkaline earth metal hydroxides, various carbonates, various borates, various phosphates, ammonia, various ammonium salts, various amines and polyethyleneimine, High molecular weight bases such as polybulamine can be used. Of these, alkali metal hydroxides are most preferred because of their low cost and great treatment effect.
  • Examples of acids include various inorganic acids such as sulfuric acid, phosphoric acid, hydrochloric acid, and nitric acid, various organic acids such as acetic acid, formic acid, benzoic acid, and phenol, and various high molecular weight acids such as polyacrylic acid and polystyrene sulfonic acid. It can be used. Among these, polyacrylic acid is most preferable from the viewpoint of acidity and solubility among those preferred to high molecular weight acids because they have a large treatment effect and little adverse effect on other physical properties. .
  • the solvent of the basic or acidic solution various inorganic and organic solvents can be used.
  • aromatic hydrocarbons such as hexane, heptane, octane, decane, petroleum ether, kerosene, lignin, paraffin and other aliphatic hydrocarbons, acetone, methyl ethyl ketone, methyl isobutyl ketone and other ketones, acetic acid
  • esters such as ethyl acetate, butylacetate, methyl benzoate, dioctyl phthalate, etc., jetyl ether, tetrahydrofuran, di
  • aprotic polar solvents such as dimethylformamide, dimethylacetamide, N-methyl-2-pyrrolidone, dimethylimidazolidinone, hexamethylphosphoric triamide, dimethyl sulfoxide, methylene chloride, chloroform, dichloroethane, Halogen solvents such as trichloroethane and trichlorethylene, and fluorocarbon solvents.
  • water is most preferable from the viewpoints of economy, ease of handling, chemical stability, and the like.
  • the solvent a mixture of two or more substances can be used.
  • the basic or acidic solution used in the present invention may contain a basic or acidic substance and components other than the solvent.
  • the ophthalmic lens is treated with a force S to remove a basic or acidic substance by washing after the base treatment or the acid treatment.
  • the cleaning solvent various inorganic and organic solvents can be used.
  • the cleaning solvent a mixture of two or more kinds of solvents may be used.
  • the cleaning solvent may contain components other than the solvent, such as inorganic salts, surfactants, and cleaning agents.
  • the modification treatment may be performed on the entire ophthalmic lens, or may be performed only on a part of the ophthalmic lens, for example, only on the surface.
  • only the surface is modified, only the water wettability of the surface can be improved without greatly changing the properties of the entire ophthalmic lens, and the surface water of the ophthalmic lens using the polymer of the present invention can be improved.
  • internal wettability is achieved by polymerizing the monomer mixture at the time of polymerization with a hydrophilic polymer added, and retaining the hydrophilic polymer in the ophthalmic lens to improve the surface water wettability.
  • hydrophilic polymers used as internal wetting agents include polybulu cyclic amides such as polybulurpyrrolidone, polybulu cyclic amines such as polybutimidazole, polyacrylamides such as poly N, N-dimethylacrylamide, and polybular alcohol. And polyalcohols such as polyacrylic acid, polycarboxylic acids such as polyacrylic acid, polyethylene glycols, mixtures thereof, and copolymers. Of these, the eyes Most preferred from the viewpoint of improving the wettability of the lens surface is polybulurpyrrolidone.
  • oxygen permeability coefficient 70 X 10— U to 500 X 10— u (cm 2 / sec) mLO / (mL -h
  • the antibacterial properties of the ophthalmic lens of the present invention are as follows.
  • the average of the number of bacteria after cultivation was 3 times the initial number of bacteria before culture. If it is within 4 times the average number of times, it is considered that there is no growth and is judged to have antimicrobial effect. More preferably, it is 10% or less of the average number of control bacteria, and most preferably 1% or less of the number of control bacteria.
  • the polymer of the present invention is particularly suitable as an ophthalmic lens such as a contact lens, an intraocular lens, and an artificial cornea.
  • the obtained film-like sample was peeled from the glass plate by applying ultrasonic waves in water for 20 minutes, immersed in a 60% IPA aqueous solution at 60 ° C, and further immersed in an 80% IPA aqueous solution at 60 ° C. Impregnation such as residual monomer was extracted by immersion for 2 hours, and hydrated by immersing in 50% IPA aqueous solution, 25% aqueous solution, and water with gradually decreasing IPA concentration for approximately 30 minutes. It was immersed in a borate buffer solution ( ⁇ 7 ⁇ ;!-7.3) in a 200 mL glass bottle, and the glass bottle was placed in an autoclave and boiled at 121 ° C. for 30 minutes. After allowing to cool, the film-like sample was taken out from the glass bottle and immersed in a borate buffer ( ⁇ 7 ⁇ !-7.3). The obtained film-like sample was cut into 3 cm squares to obtain antibacterial evaluation samples.
  • Example 1 After the sample obtained in Example 1 was vacuum-dried at 40 ° C for 16 hours, 2 g was taken, ultrasonically washed in distilled water for 30 minutes, then immersed in 2-propanol at 60 ° Heated at C for 24 hours. Evaporate the solvent from the extract using an evaporator, and then reduce the pressure using a vacuum pump. Then, when the residual solvent was completely removed and the weight was measured, the extract was 56.9 mg. In addition, from the infrared absorption spectrum, this extract was found to be a PVP / Burmethyl imidazolium glycide copolymer. From this, it was confirmed that the polymer of Example 1 was not dispersed with a polymer compound having a monomer unit having an ammonium group in the molecule.
  • N-Buylimidazole (4.71 g, 50 mmol)
  • iodinated notachinole (12. 01 g, 50 mmol)
  • 2,6-di-tert-butyl 4-methylphenol BHT, 0.1672 g
  • the monomer (lg) represented by the formula (xl) obtained in Synthesis Example 1 above, 3,7 dimethyl-3-octanol (lg), and photoinitiator Irgacure 1850 (0.02 g) were mixed and stirred.
  • This monomer mixture was degassed under an argon atmosphere and poured into a petri dish having a diameter of 5 cm in a glove box under a nitrogen atmosphere.
  • Light irradiation Toshiba FL6D fluorescent lamp, 8.4 kilolux, 15 minutes
  • dissolved in as little methanol as possible dropped into 500 mL of ethyl acetate with stirring, and allowed to stand at 5 ° C for 3 hours.
  • the monomer yarn is formed by a silicone compound represented by the formula (yl) (23 parts by weight), the following formula (y3) [0084] [Chemical Formula 13]
  • a mixture of the obtained poly (buluoctylimidazolium iodide) (3.7 parts by weight), photoinitiator Inore Gacure 1850 (1 part by weight), 3,7-dimethyl-3-octanol (14 parts by weight)
  • the sample was subjected to the same polymerization and post-treatment as in Example 1 to obtain a sample for antibacterial evaluation.
  • a sample for antibacterial evaluation was obtained by performing polymerization and post-treatment according to the method of Example 2 except that the amount of poly (buluoctylimidazolium iodide) was changed as shown in Table 1 below.
  • a film sample was obtained in the same manner as in Example 1 except that the polymer compound was not added to the monomer mixture. It was cut into 3 cm square and used as an antibacterial evaluation sample.
  • extraction was carried out by changing the solvent to methanol, ethanol, toluene, hexane, acetone, methyl ethyl ketone, ethyl acetate, butyl acetate, tetrahydrofuran, or dimethyl sulfoxide, all of which were 0.1 weight of the dry weight of the sample. % Extract was not extracted.
  • the film-like sample obtained in Comparative Example 1 was placed in a 50 mL screw tube and immersed in an aqueous solution of 1.7% PVP / polymethylvinylimidazolium chloride (95/5) at room temperature for 16 hours.
  • Example 1 and Comparative Example 2 were immersed in 300 mL of distilled water, washed with ultrasonic waves for 15 minutes, then taken out and subjected to the same antibacterial evaluation as described above.
  • the results are shown in Table 4 below, whereas the film-like sample obtained in Comparative Example 2 that was only immersed in an antibacterial polymer aqueous solution lost its antibacterial properties and showed bacterial growth.
  • the film-like sample obtained in Example 1 was shown to have sufficient antibacterial properties even after ultrasonic cleaning.
  • extraction was carried out by changing the solvent to methanol, ethanol, toluene, hexane, acetone, methyl ethyl ketone, ethyl acetate, butyl acetate, tetrahydrofuran, or dimethyl sulfoxide, all of which were 0.1 weight of the dry weight of the sample. % Extract was not extracted.

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Materials For Medical Uses (AREA)
  • Eyeglasses (AREA)
  • Prostheses (AREA)
  • Macromonomer-Based Addition Polymer (AREA)

Abstract

Disclosed is an ocular lens having excellent antibacterial properties which do not deteriorate even when the ocular lens is rinsed with water. The ocular lens is characterized in that it is obtained by dispersing a polymer compound (A), which contains a monomer unit having an ammonium group in a molecule, into a hydrogel (B).

Description

明 細 書  Specification
眼用レンズ  Ophthalmic lens
技術分野  Technical field
[0001] 本発明は、眼用レンズに関するもので、該眼用レンズはコンタクトレンズ、眼内レン ズ、人工角膜などに特に好適に用いられる。  The present invention relates to an ophthalmic lens, and the ophthalmic lens is particularly preferably used for a contact lens, an intraocular lens, an artificial cornea, and the like.
背景技術  Background art
[0002] コンタクトレンズ装用者に見られる問題の一つに細菌による感染の問題がある。そ の対策の一つとして、コンタクトレンズ洗浄 ·保存液に抗菌性成分を含有することによ り、コンタクトレンズ保存中に細菌が付着するのを抑制する方法が知られている(例え ば、特許文献 1)。し力、しながら、この方法では抗菌性成分は洗浄'保存液から取り出 して軽く水洗するだけでも抗菌性成分が洗レ、流されてしまい、コンタクトレンズ使用中 の細菌感染を抑制する目的には十分な効果が得られにくいという問題があった。 特許文献 1 :特表 2006— 509532  [0002] One of the problems seen in contact lens wearers is the problem of bacterial infection. As one of the countermeasures, there is known a method for suppressing the adhesion of bacteria during contact lens storage by including an antibacterial component in the contact lens cleaning / preserving solution (for example, patents). Reference 1). However, with this method, the antibacterial component can be washed and washed even if it is removed from the washing solution and lightly washed with water. Has a problem that it is difficult to obtain a sufficient effect. Patent Document 1: Special Table 2006—509532
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0003] 本発明は、抗菌性に優れ水洗等しても抗菌性が低下しない眼用レンズを提供する ことを目白勺とする。 [0003] It is an object of the present invention to provide an ophthalmic lens that is excellent in antibacterial properties and does not deteriorate even when washed with water.
課題を解決するための手段  Means for solving the problem
[0004] 上記の目的を達成するために、本発明は下記の構成を有する。すなわち、 In order to achieve the above object, the present invention has the following configuration. That is,
(1) 分子内にアンモユウム基を有するモノマー単位を有する高分子化合物 (A)が、 ノ、イド口ゲル (B)中に分散されてなることを特徴とする眼用レンズ。  (1) An ophthalmic lens comprising: a polymer compound (A) having a monomer unit having an ammoium group in the molecule, dispersed in a gel or gel (B).
(2)眼用レンズ中のアルコール性水酸基数を OH、アンモニゥム窒素の数を Nで表す とき、 N/OH比が 0. 001 -0. 5であることを特徴とする上記(1)記載の眼用レンズ。  (2) When the number of alcoholic hydroxyl groups in the ophthalmic lens is represented by OH and the number of ammonium nitrogen by N, the N / OH ratio is 0.001 to 0.5. Ophthalmic lens.
(3) 前記ハイド口ゲル (B)が、シリコーン成分を 20重量%以上含有するシリコーン ハイド口ゲルであることを特徴とする上記(1)または(2)記載の眼用レンズ。  (3) The ophthalmic lens according to (1) or (2) above, wherein the hide-mouth gel (B) is a silicone-hide mouth gel containing a silicone component at 20% by weight or more.
(4) 前記ハイド口ゲル(B)中のシリコーン成分中のケィ素原子数のうち、 50%以上 が極性シリコーン成分のケィ素原子であることを特徴とする上記(3)記載の眼用レン ズ。 (4) The ophthalmic lens according to the above (3), wherein 50% or more of the number of key atoms in the silicone component in the hide mouth gel (B) is a key atom of the polar silicone component .
(5) 前記極性シリコーン成分の極性基力 S、水酸基、アミド基、カルボキシル基、ァミノ 基、カーボネート基、カーバメート基、スルホンアミド基、スルホン酸基、ホスホン酸基 (5) Polar basic force S, hydroxyl group, amide group, carboxyl group, amino group, carbonate group, carbamate group, sulfonamide group, sulfonic acid group, phosphonic acid group of the polar silicone component
、メトキシェチル基、メトキシエトキシェチル基、ヒドロキシェチル基、ヒドロキシエトキシ ェチル基からなる群から選ばれた基であることを特徴とする上記 (4)記載の眼用レン ズ。 The ophthalmic lens as described in (4) above, which is a group selected from the group consisting of methoxyethyl group, methoxyethoxyethyl group, hydroxyethyl group, and hydroxyethoxyethyl group.
(6) 前記シリコーン成分のうち、少なくとも 1種類が下記一般式 (a)  (6) At least one of the silicone components is represented by the following general formula (a)
M-L- Sx (a)  M-L- Sx (a)
で表されるシリコーンモノマーから得られる構造を有することを特徴とする上記(3)〜 (5)のいずれかに記載の眼用レンズ。  The ophthalmic lens according to any one of (3) to (5) above, which has a structure obtained from a silicone monomer represented by
(Mはラジカル重合可能な重合性基を表す。 Lは炭素数 1〜20の置換されていてもよ い 2価の有機基を表す。 Aはシロキサニル基を表す。 )  (M represents a polymerizable group capable of radical polymerization. L represents an optionally substituted divalent organic group having 1 to 20 carbon atoms. A represents a siloxanyl group.)
(7) 前記式 (a)中の Lが下記一般式 (b)、(c)  (7) L in the above formula (a) is the following general formula (b), (c)
[0005] [化 1] [0005] [Chemical 1]
—— (CH2)j—— (b ) —— (CH 2 ) j—— (b)
OH (CH2CHCH2)k— O—— (CH2)m― ( c ) OH (CH 2 CHCH 2 ) k — O—— (CH 2 ) m — (c)
[0006] の!/、ずれかであることを特徴とする上記(6)記載の眼用レンズ。 [0006] The ophthalmic lens as described in (6) above, wherein!
(jは 1〜20の整数を表す。 kは 1〜6の整数を表し、 mは 1〜; 17の整数を表す。ただし 、 3k+m≤20である。 )  (j represents an integer from 1 to 20. k represents an integer from 1 to 6, m represents an integer from 1 to 17; however, 3k + m≤20.)
(8) 前記式 (a)中の Lが一般式 (c)で表される基であることを特徴とする上記(7)記 載の眼用レンズ。  (8) The ophthalmic lens according to (7), wherein L in the formula (a) is a group represented by the general formula (c).
(9) 前記シリコーンモノマーのうち、少なくとも一種類が下記式 (d)、(e)および (g) [0007] [化 2] (9) At least one of the silicone monomers is represented by the following formulas (d), (e) and (g) [0007] [Chemical Formula 2]
Figure imgf000004_0001
Figure imgf000004_0001
[0008] 力、らなる群から選ばれたモノマーであることを特徴とする上記(6)に記載の眼用レン ズ。 [0008] The ophthalmic lens as described in (6) above, which is a monomer selected from the group consisting of force and the like.
(10) 前記シリコーンモノマーのうち、少なくとも 1種類が式(e)および (g)からなる群 力、ら選ばれたシリコーンモノマーであることを特徴とする上記(9)記載の眼用レンズ。 (10) The ophthalmic lens according to the above (9), wherein at least one of the silicone monomers is a silicone monomer selected from the group consisting of the formulas (e) and (g).
(11) 前記高分子化合物 (A)の含有量が 0. 0;!〜 20重量%であることを特徴とする 前記(1)〜(10)の!/、ずれかに記載の眼用レンズ。 (11) The ophthalmic lens according to (1) to (10), wherein the content of the polymer compound (A) is 0.0;! To 20% by weight. .
(12) 前記アンモニゥム基を有するモノマーが下記一般式 (f)  (12) The monomer having an ammonium group is represented by the following general formula (f)
[0009] [化 3] [0009] [Chemical 3]
Figure imgf000004_0002
[0010] で表されることを特徴とする上記(1 )〜(; 1 1 )のいずれかに記載の眼用レンズ。 (R1は 炭素数 1〜30の置換されていてもよいアルキル基を表す。 R2〜R7は炭素数 1〜20 の置換されて!/、てもよ!/、アルキル基または炭素数 6〜20の置換されて!/、てもよ!/ヽァリ 一ル基を表す。 R2と は環を形成していてもよい。 X—は任意のァニオンを表す。 )
Figure imgf000004_0002
[0010] The ophthalmic lens according to any one of (1) to (; 1 1) above, (R 1 represents an optionally substituted alkyl group having 1 to 30 carbon atoms. R 2 to R 7 are substituted with 1 to 20 carbon atoms! /, May! /, Alkyl groups or carbon atoms. Represents 6 to 20 substituted! /, May! / Aryl groups, R 2 may form a ring, and X— represents any anion.
( 13) 高分子化合物 (A)と混合した状態で、ハイド口ゲル (B)のモノマーまたはマク 口モノマーを重合させて得られることを特徴とする上記(1 )〜(; 12)のレ、ずれかに記載 の眼用レンズ。 (13) The above-mentioned (1) to (; 12), characterized by being obtained by polymerizing the monomer of the mouth-opening gel (B) or the macro-mouth monomer in a state of being mixed with the polymer compound (A). The ophthalmic lens according to any one of the above.
( 14) 眼用レンズがコンタクトレンズであることを特徴とする上記(1 )〜(; 13)のいず れかに記載の眼用レンズ。  (14) The ophthalmic lens according to any one of (1) to (; 13) above, wherein the ophthalmic lens is a contact lens.
発明の効果  The invention's effect
[0011] 本発明によれば、抗菌性に優れ水洗等しても抗菌性が低下しない眼用レンズを得 ること力 Sでさる。  [0011] According to the present invention, it is possible to obtain an ophthalmic lens that has excellent antibacterial properties and does not deteriorate even when washed with water.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0012] 本発明の眼用レンズは網目構造を有する親水性ポリマーであるハイド口ゲル中に、 分子内にアンモニゥム基を有する高分子化合物を分散させてなる。本発明において は、ハイド口ゲル内に該高分子化合物が分散されているとは、単にハイド口ゲル表面 に付着している場合を含まず、水を用いて超音波洗浄により眼用レンズ表面を洗浄 した後、有機溶媒で眼用レンズ中に含まれる高分子化合物を抽出した際に、分子内 にアンモユウム基を有する高分子化合物が抽出されるようなものを指す。該抽出操作 により、分子内にアンモニゥム基を有する高分子化合物が抽出された場合には、該 ノ、イド口ゲル中に該高分子化合物が分散されていると判断する。具体的には有機溶 媒としてメタノール、エタノール、 2—プロパノール、トルエン、へキサン、アセトン、メチ ルェチルケトン、酢酸ェチル、酢酸ブチル、テトラヒドロフラン、ジメチルスルホキシド を用いて抽出し、これらのうち少なくとも 1種類によって、ハイド口ゲルの乾燥重量の 0 . 1 %以上分子内にアンモニゥム基を有する高分子化合物が抽出された場合は該高 分子化合物が分散されてレ、ると判断する。 [0012] The ophthalmic lens of the present invention is obtained by dispersing a polymer compound having an ammonium group in a molecule in a hyde mouth gel which is a hydrophilic polymer having a network structure. In the present invention, that the polymer compound is dispersed in the hyde mouth gel does not include the case where the polymer compound is simply attached to the hyde mouth gel surface, and the ophthalmic lens surface is cleaned by ultrasonic cleaning using water. After washing, when the polymer compound contained in the ophthalmic lens is extracted with an organic solvent, the polymer compound having an ammonium group in the molecule is extracted. When a polymer compound having an ammonium group in the molecule is extracted by the extraction operation, it is determined that the polymer compound is dispersed in the gel. Specifically, extraction is performed using methanol, ethanol, 2-propanol, toluene, hexane, acetone, methyl ethyl ketone, ethyl acetate, butyl acetate, tetrahydrofuran, dimethyl sulfoxide as an organic solvent, and at least one of these is used. When a polymer compound having an ammonium group in the molecule is extracted by 0.1% or more of the dry weight of the hide-mouthed gel, it is determined that the polymer compound is dispersed.
[0013] 本発明の眼用レンズのハイド口ゲル (B)に用いられる親水性モノマーとしては、重 合可能であれば特に制限はなぐ(メタ)アタリロイル基、スチリル基、ァリル基、ビュル 基、および他の重合可能な炭素 ·炭素不飽和結合を有するモノマーを使用すること ができる。 [0013] The hydrophilic monomer used in the hide-mouthed gel (B) of the ophthalmic lens of the present invention is not particularly limited as long as it can be polymerized. (Meth) Atalyloyl group, styryl group, allyl group, bulle Monomers having other groups and other polymerizable carbon-carbon unsaturated bonds can be used.
[0014] 以下、その例をいくつか挙げる力 S、本発明はこれらに限定されるものではない。 (メ タ)アクリル酸、ィタコン酸、クロトン酸、ビュル安息香酸などのカルボン酸類、 2—ヒド ロキシェチル (メタ)アタリレートなどの水酸基を有する(メタ)アタリレート類、 N, N—ジ メチルアクリルアミドなどの(メタ)アクリルアミド類、 N—ビュルピロリドン、 N—ビニルイ ミダゾールなどである。これらのうち、得られるシリコーンポリマーの機械的特性や長 期保存安定性の点で好ましいのは、 N, N—ジメチルアクリルアミドなどの(メタ)アタリ ルアミド類である。本発明の眼用レンズが十分な酸素透過性を有するためには、ハイ ドロゲルはさらにシリコーン成分を含有したシリコーンハイド口ゲルであることが好まし い。シリコーンハイド口ゲル中のシリコーン成分の含有量は、少ないと眼用レンズを連 続装用するのに必要な酸素透過性が得られず、多いと親水性成分との相溶性が得 られにくくなることから、各種モノマーの重量の合計を 100重量部とした時に、シリコ ーンモノマーの含有量は 20〜80重量部が好ましぐ 30〜80重量部がより好ましぐ 50〜80重量部が最も好まし!/、。  [0014] In the following, force S that gives some examples, the present invention is not limited to these. (Meth) acrylic acid, itaconic acid, crotonic acid, carboxylic acids such as butyl benzoic acid, (meth) acrylates with hydroxyl groups such as 2-hydroxyxetyl (meth) acrylate, N, N-dimethyl acrylamide, etc. (Meth) acrylamides, N-Buylpyrrolidone, N-Vinylimidazole and the like. Of these, (meth) atrylamides such as N, N-dimethylacrylamide are preferred in view of the mechanical properties and long-term storage stability of the resulting silicone polymer. In order for the ophthalmic lens of the present invention to have sufficient oxygen permeability, the hydrogel is preferably a silicone hydride gel further containing a silicone component. If the content of the silicone component in the silicone hydride gel is small, the oxygen permeability necessary for continuous use of the ophthalmic lens cannot be obtained, and if it is large, the compatibility with the hydrophilic component is difficult to obtain. Therefore, when the total weight of various monomers is 100 parts by weight, the content of the silicone monomer is preferably 20 to 80 parts by weight, more preferably 30 to 80 parts by weight, and most preferably 50 to 80 parts by weight. ! /
[0015] 本発明の眼用レンズのハイド口ゲル(B)がシリコーンハイド口ゲルである場合、疎水 性であるシリコーン成分と、親水性であるアンモニゥム基を有するモノマー単位を有 する高分子化合物 (A)との間に十分な相溶性を得るためには、シリコーン成分中の ケィ素原子数のうち、 30%以上が極性シリコーン成分のケィ素原子であることが好ま しぐ 40%以上がより好ましぐ 50%以上が最も好ましい。  [0015] When the hyde mouth gel (B) of the ophthalmic lens of the present invention is a silicone hyde mouth gel, a polymer compound having a hydrophobic silicone component and a monomer unit having a hydrophilic ammonium group ( In order to obtain sufficient compatibility with (A), it is preferable that 30% or more of the number of key atoms in the silicone component is a key atom in the polar silicone component, and more than 40% is more. 50% or more is most preferable.
[0016] ここで、極性シリコーン成分とは分子内に極性基を有する極性シリコーンモノマーを 重合して得られる構造を表す。極性基の例としては、水酸基、アミド基、カルボキシノレ 基、アミノ基、カーボネート基、カーバメート基、スルホンアミド基、スルホン酸基、ホス ホン酸基、メトキシェチル基、メトキシエトキシェチル基、ヒドロキシェチル基、ヒドロキ シエトキシェチル基などを挙げることができる。  [0016] Here, the polar silicone component represents a structure obtained by polymerizing a polar silicone monomer having a polar group in the molecule. Examples of polar groups include hydroxyl groups, amide groups, carboxynole groups, amino groups, carbonate groups, carbamate groups, sulfonamide groups, sulfonic acid groups, phosphonic acid groups, methoxyethyl groups, methoxyethoxyethyl groups, hydroxyethyl groups. Group, hydroxyethoxyethyl group and the like.
[0017] また、本発明の眼用レンズがシリコーンノヽイド口ゲルである場合、透明性を向上させ るためには親水性モノマーとして、特に 2—ヒドロキシェチル (メタ)アタリレートなどの 水酸基を有する(メタ)アタリレートモノマーを共重合させることが好まし!/、。使用する 場合の使用量は、少なすぎると透明性向上の効果が得られにくぐ多すぎるとポリマ 一物性に影響を及ぼすことから、 0. ;!〜 25重量部が好ましぐ 0. 5〜20重量部がよ り好ましく、 1. 0〜; 15重量部が最も好ましい。また、眼用レンズ中の水酸基数を OH、 アンモニゥム窒素の数を Nとした場合、 N/OH比は小さすぎると十分な抗菌性が得 られず、大きすぎると眼用レンズが十分な透明性を得られないことから、 0. 001-0. 5カ好ましく、 0. 005〜0. 4カより好ましく、 0. 0;!〜 0. 3カ^!も好ましレヽ。また、 N/ OH比の測定法は、ハイド口ゲルおよび抗菌高分子中の各成分の種類や量に応じて 選択されるが、その例として、核磁気共鳴法 (NMR)、赤外分光法 (IR)、元素分析、 全反射型赤外吸収測定 (ATR)、紫外分光法 (UV)、滴定法等の一般的な各種測 定方法、およびそれらの組み合わせを挙げることができる。 本発明の眼用レンズに 用いられるシリコーンハイド口ゲルの重合方法としては、シリコーンモノマー、親水性 モノマー、架橋モノマー等の各種モノマーの混合液を重合して得る方法、シリコーン モノマー、親水性モノマー等の各種モノマーを単独重合もしくは共重合した後、重合 性基を導入したマクロモノマーを重合して得る方法などが挙げられる。 [0017] Further, when the ophthalmic lens of the present invention is a silicone nodule gel, in order to improve transparency, a hydroxyl group such as 2-hydroxyethyl (meth) acrylate is particularly used as a hydrophilic monomer. It is preferred to copolymerize (meth) acrylate monomers that have! use If the amount used is too small, the effect of improving transparency cannot be obtained. If too much is used, the physical properties of the polymer will be affected, so 0.;! ~ 25 parts by weight is preferred 0.5 to 20 parts by weight Parts are more preferred, 1.0-- 15 parts by weight is most preferred. If the number of hydroxyl groups in the ophthalmic lens is OH and the number of ammonium nitrogen is N, if the N / OH ratio is too small, sufficient antibacterial properties cannot be obtained, and if it is too large, the ophthalmic lens has sufficient transparency. In this case, 0.001 to 0.5 is preferable, 0.005 to 0.4 is more preferable, 0.0;! To 0.3 is also preferable. In addition, the method for measuring the N / OH ratio is selected according to the type and amount of each component in the hide-mouth gel and the antibacterial polymer, and examples thereof include nuclear magnetic resonance (NMR) and infrared spectroscopy. (IR), elemental analysis, total reflection infrared absorption measurement (ATR), ultraviolet spectroscopy (UV), various general measurement methods such as titration method, and combinations thereof. Examples of the polymerization method of the silicone hydride gel used in the ophthalmic lens of the present invention include a method obtained by polymerizing a mixture of various monomers such as a silicone monomer, a hydrophilic monomer, and a crosslinking monomer, a silicone monomer, a hydrophilic monomer, and the like. Examples include a method in which various monomers are homopolymerized or copolymerized, and then a macromonomer having a polymerizable group introduced is polymerized.
[0018] 本発明のシリコーンハイド口ゲルをモノマーから重合して得る場合のシリコーンモノ マーは、 2つ以上の重合性基を有すると架橋剤として機能し、得られるシリコーンノ、ィ ドロゲルの弾性率が高くなりすぎることから、下記一般式 (a) [0018] The silicone monomer obtained by polymerizing the silicone hydride gel of the present invention from a monomer functions as a cross-linking agent when it has two or more polymerizable groups, and the resulting elastic modulus of the silicone nodulogel Is too high, the following general formula (a)
M-L- Sx (a)  M-L- Sx (a)
で表される、分子内に重合性基を一つ有する構造のシリコーンモノマーが好まし!/、。  A silicone monomer having a structure having one polymerizable group in the molecule is preferred! /.
[0019] 式 (a)中の Μはラジカル重合可能な重合性基を表す。ラジカル重合可能な重合基 の例としては、ビニノレ基、ァリノレ基、ビニロキシ基、ァリロキシ基、ビュル力ルバメート 基、ァリルカルバメート基、ビュルカーボネート基、ァリルカーボネート基、メタタリロイ ル基、アタリロイル基、スチリル基などが挙げられる。これらのうち、得られるポリマーの 弾性率の点で好ましいのはアタリロイル基、メタクリロイル基である。 In the formula (a), Μ represents a polymerizable group capable of radical polymerization. Examples of the polymerizable group capable of radical polymerization include vinylene group, vinylol group, vinyloxy group, aryloxy group, bull force rubamate group, aryl carbamate group, bull carbonate group, aryl carbonate group, metatalolyl group, allyloyl group, styryl group. Groups and the like. Of these, the attalyloyl group and the methacryloyl group are preferable from the viewpoint of the elastic modulus of the obtained polymer.
[0020] 式 (a)中、 Lは炭素数;!〜 20の置換されていてもよい 2価の有機基を表す。得られる ポリマーの弾性率を下げるためにはアルキレン基がより好ましぐさらに親水性モノマ 一との相溶性を得るためには水酸基、エチレンォキシド構造を有することがより好まし い。その例としてメチレン基、エチレン基、プロピレン基、 1 メチルエチレン基、 2—メ チルエチレン基、 n プロピレン基、 n ブチレン基、 2—メチルプロピレン基、 2, 2— ジメチルプロピレン基、 n ペンチレン基などの 2価の炭化水素基、 2—ヒドロキシプロ ピレン基、 2 ヒドロキシブチレン基、 3 ヒドロキシブチレン基などの水酸基を有する 2価の有機基、下記式 (L一;!)〜(L 3)などの式で表されるようなエーテル結合を 有する 2価の有機基、および下記式(L 4)、 (L 5)などの式で表されるようなエー テル結合と水酸基を併せもつ 2価の有機基などが挙げられる。 [0020] In the formula (a), L represents an optionally substituted divalent organic group having carbon number; In order to lower the elastic modulus of the obtained polymer, an alkylene group is more preferable. In order to obtain compatibility with a hydrophilic monomer, it is more preferable to have a hydroxyl group or an ethylene oxide structure. Examples include a methylene group, an ethylene group, a propylene group, a 1 methylethylene group, a 2-methyl group. Divalent hydrocarbon groups such as tilethylene, n-propylene, n-butylene, 2-methylpropylene, 2,2-dimethylpropylene, n-pentylene, 2-hydroxypropylene, 2-hydroxybutylene, 3 A divalent organic group having a hydroxyl group such as a hydroxybutylene group, a divalent organic group having an ether bond as represented by the following formulas (L1 ;!) to (L3), and the following formula ( Examples thereof include divalent organic groups having both an ether bond and a hydroxyl group represented by formulas such as L 4) and (L 5).
[0021] [化 4] [0021] [Chemical 4]
Figure imgf000008_0001
Figure imgf000008_0001
[0022] これらのうち、式(b)または(c) [0022] Of these, the formula (b) or (c)
[0023] [化 5] (CH2); ( b ) [0023] [Chemical 5] (CH 2 ); (b)
OH  OH
(CH2CHCH2)k— O—— (CH2)m— ( c ) (CH 2 CHCH 2 ) k — O—— (CH 2 ) m — (c)
[0024] で表される基が好ましぐ式 (c)で表される基がより好ましい。さらに、式 (c)中の k= l[0024] The group represented by the formula (c) is more preferred. Furthermore, k = l in equation (c)
、 mが 1〜 5である場合が最も好ましい。 M is most preferably 1-5.
[0025] 式(a)中、 Sxはシロキサニル基を表す。ここで、シロキサニル基は構造中に少なくと も一つの Si— O— Si結合を有する基を表す。 In the formula (a), Sx represents a siloxanyl group. Here, the siloxanyl group represents a group having at least one Si—O—Si bond in the structure.
[0026] 上記一般式(a)で表されるシリコーンモノマーは、下記一般式(a ' )で表されるもの であることが好ましい。 [0026] The silicone monomer represented by the general formula (a) is preferably the one represented by the following general formula (a ').
[0027] [化 6] [0027] [Chemical 6]
Figure imgf000009_0001
Figure imgf000009_0001
[0028] nは 0〜200の整数を表す。 a、 b、 cはそれぞれ独立に 0〜20の整数を表す。 n + a + b + cでシリコーン化合物中のシロキサン結合の数を表すが、 n + a + b + cの数が 少なすぎると眼用レンズやコンタクトレンズに必要とされる酸素透過性が十分に得ら れず、多すぎると共重合成分として用いられることの多い種々の親水性モノマーとの 相溶性が低くなり、透明なレンズが得られないことから 1〜260が好ましぐ 2〜; 100が より好ましく、 2〜50が最も好ましい。 [0028] n represents an integer of 0 to 200. a, b and c each independently represents an integer of 0 to 20. n + a + b + c represents the number of siloxane bonds in the silicone compound. If the number of n + a + b + c is too small, the oxygen permeability required for ophthalmic lenses and contact lenses will be sufficient. If the amount is too large, the compatibility with various hydrophilic monomers often used as a copolymerization component is reduced, and a transparent lens cannot be obtained. More preferably, 2 to 50 is most preferable.
[0029] Ai A11はそれぞれ置換されていてもよい炭素数 1〜20のアルキル基または置換 されていてもよい炭素数 6〜20のァリール基を表す。上記の構造で表される置換基 の中で、かかる置換基を有した化合物が工業的に比較的安価に入手できることから [0029] Ai A 11 represents an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted aryl group having 6 to 20 carbon atoms. Substituent represented by the above structure Among them, the compound having such a substituent is industrially available at a relatively low cost.
)シリル基、ジメチルトリメチルシ口キシシリル基、ポリ(ジメチルシロキサン)基からなる 群から選ばれた基である。 ) A group selected from the group consisting of a silyl group, a dimethyltrimethyloxysilyl group, and a poly (dimethylsiloxane) group.
[0030] 一般式(a)で表されるシリコーンモノマーのうち、親水性モノマー、アンモニゥム塩 モノマーとの相溶性、重合して得られるポリマーの酸素透過性、機械的特性などの点 で好ましいのは下記式(d)、 (e)、 (g) [0030] Among the silicone monomers represented by the general formula (a), those that are preferable in terms of compatibility with hydrophilic monomers and ammonium salt monomers, oxygen permeability of polymers obtained by polymerization, mechanical properties, and the like are preferable. The following formula (d), (e), (g)
[0031] [化 7] [0031] [Chemical 7]
Figure imgf000010_0001
Figure imgf000010_0001
[0032] (式(g)中、 Qは炭素数 1〜8のアルキル基を表す。 pは 1〜20の整数を表す。) で表されるシリコーンモノマーである。さらに、ポリビュルピロリドンなどの内部湿潤剤 と混合しても透明なシリコーンポリマーが容易に得られることから、式 (e)、式 (i)で表 されるような分子内に水酸基を有するシリコーンモノマーが最も好ましい。 (In the formula (g), Q represents an alkyl group having 1 to 8 carbon atoms. P represents an integer of 1 to 20). Furthermore, since a transparent silicone polymer can be easily obtained even when mixed with an internal wetting agent such as polybulurpyrrolidone, a silicone monomer having a hydroxyl group in the molecule as represented by formula (e) or formula (i). Is most preferred.
[0033] 本発明においてマクロモノマーとは、分子量 800以上で重合性基を 1つ以上有する モノマーである。  [0033] In the present invention, the macromonomer is a monomer having a molecular weight of 800 or more and having one or more polymerizable groups.
[0034] 本発明の眼用レンズに用いるシリコーンノヽイド口ゲルをマクロモノマーから得る場合 には、上記の各種シリコーンモノマーを単独重合した後、重合性基を導入し、各種親 水性モノマー等と共重合する方法や、各種シリコーンモノマー、各種親水性モノマー 等を共重合した後、重合性基を導入して重合する方法を用いることができる。これら のうち、シリコーン成分と親水性成分の相溶性を高めやすいことから好ましいのは、 各種シリコーンモノマーと各種親水性モノマーを共重合した後、重合性基を導入して 重合する方法である。 [0034] When the silicone nodule gel used in the ophthalmic lens of the present invention is obtained from a macromonomer, the above-mentioned various silicone monomers are homopolymerized and then introduced with a polymerizable group to co-polymerize with various hydrophilic monomers and the like. Polymerization method, various silicone monomers, various hydrophilic monomers And the like, and then polymerizing by introducing a polymerizable group. Among these, a method in which various silicone monomers and various hydrophilic monomers are copolymerized and then a polymerizable group is introduced and polymerized is preferable because compatibility between the silicone component and the hydrophilic component is easily increased.
[0035] シリコーンマクロモノマーの分子量は低すぎるとマクロモノマーを用いることの利点 の一つである重合収縮抑制の効果が十分ではなぐ高すぎるとマクロモノマーの粘度 が高くなりすぎて取扱いが難しくなつたり、重合溶媒に対する溶解性が低下するとい つた問題があることから、 1000〜; 100万力 S好ましく、 3000〜50万力 Sより好ましく、 50 00〜; 10万が最も好ましい。  [0035] If the molecular weight of the silicone macromonomer is too low, one of the advantages of using the macromonomer is that the effect of inhibiting polymerization shrinkage is not sufficient, and if the molecular weight is too high, the viscosity of the macromonomer becomes too high and handling becomes difficult. From the viewpoint of lowering the solubility in the polymerization solvent, 1000 to 1,000,000 S is preferable, 3000 to 500,000 S is more preferable, and 500 00 to 100,000 is most preferable.
[0036] 本発明の眼用レンズに用いられる高分子化合物を構成するアンモニゥム塩モノマ 一は分子内に重合性基とアンモニゥムカチオンを有するモノマーであればよい。重合 性基はラジカル重合可能であれば特に制限はなぐ(メタ)アタリロイル基、(メタ)ァク リルアミド基、スチリル基、ァリル基、ビュル基、および他のラジカル重合可能な炭素- 炭素不飽和結合を有する基が含まれる。また、アンモニゥムカチオンは窒素原子上 の重合性基につながる一つ以外の三つの置換基力 それぞれ独立に置換されてい てもよレ、炭素数 1〜20のアルキル基または置換されて!/、てもよ!/、炭素数 6〜20のァリ ール基であり、それらの置換基は互いに環を形成していてもよい。より具体的な構造 の例を挙げると下記一般式 (f)、 (h)、 (i)  [0036] The ammonium salt monomer constituting the polymer compound used in the ophthalmic lens of the present invention may be any monomer having a polymerizable group and an ammonium cation in the molecule. The polymerizable group is not particularly limited as long as it can be radically polymerized. (Meth) Ataryloyl group, (meth) acrylamido group, styryl group, allyl group, bur group, and other radically polymerizable carbon-carbon unsaturated bonds A group having In addition, the ammonium cation may be independently substituted with three substituent groups other than one leading to a polymerizable group on the nitrogen atom, or may be substituted with an alkyl group having 1 to 20 carbon atoms or substituted! / Or, it is an aryl group having 6 to 20 carbon atoms, and these substituents may form a ring with each other. Examples of more specific structures are the following general formulas (f), (h), (i)
[0037] [化 8] [0037] [Chemical 8]
Figure imgf000012_0001
Figure imgf000012_0001
Figure imgf000012_0002
Figure imgf000012_0002
[0039] (式 (h)、 (i)中、 R8〜R1()はそれぞれ独立に置換されていてもよい炭素数 1〜20のァ ルキル基または置換されていてもよい炭素数 6〜20のァリール基を表す。 R11は水素 またはメチル基を表す。 Zは Oまたは NHを表す。 X—は任意のァニオンを表す。 ) で表されるアンモニゥム塩モノマーなどが挙げられる。それらのうち、熱安定性と抗菌 性の点で最も好ましいのは一般式 (f)で表されるビュルイミダゾリウム塩である。 [0039] (In the formulas (h) and (i), R 8 to R 1 () are each independently an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted carbon number 6 Represents an aryl group of ˜20, R 11 represents hydrogen or a methyl group, Z represents O or NH, X— represents an arbitrary anion, and the like. Among them, the burium imidazolium salt represented by the general formula (f) is most preferable in terms of heat stability and antibacterial properties.
[0040] 一般式 (f)中、 R1は炭素数 1〜30の置換されていてもよいアルキル基を表す。炭素 数が少ないと、アンモニゥムカチオン部分の親水性によりシリコーンモノマーとの相溶 性が低下し、炭素数が多すぎると、親水性モノマーとの相溶性が低下することから、 炭素数 4〜20がより好まし!/、。 In general formula (f), R 1 represents an optionally substituted alkyl group having 1 to 30 carbon atoms. If the number of carbon atoms is small, the hydrophilicity of the ammonium cation moiety makes it compatible with the silicone monomer. When the number of carbon atoms is too low, the compatibility with hydrophilic monomers decreases, so 4 to 20 carbon atoms are more preferred! /.
[0041] 一般式(f)中、 R2〜R7は炭素数 1〜20の置換されていてもよいアルキル基または 炭素数 6〜20の置換されて!/、てもよ!/、ァリール基を表す。 R2と は環を形成して!/ヽ てもよい。 In general formula (f), R 2 to R 7 are optionally substituted alkyl groups having 1 to 20 carbon atoms or substituted with 6 to 20 carbon atoms! /, May! /, Aryl Represents a group. R 2 may form a ring! / ヽ.
[0042] 一般式 (f)中、 X—は任意のァニオンを表す。その例として、フッ化物イオン、塩化物 イオン、臭化物イオン、ヨウ化物イオンなどのハロゲン化物イオン、水酸化物イオン、 硫酸イオン、硝酸イオン、四フッ化ホウ素イオンなどが挙げられる。それらのうち、合 成の容易さの点でハロゲン化物イオンが最も好ましい。  In the general formula (f), X— represents an arbitrary anion. Examples thereof include halide ions such as fluoride ions, chloride ions, bromide ions, iodide ions, hydroxide ions, sulfate ions, nitrate ions, boron tetrafluoride ions, and the like. Of these, halide ions are most preferred from the viewpoint of ease of synthesis.
[0043] 本発明の高分子化合物はアンモニゥム塩モノマーのホモポリマーであっても、他の モノマーとのコポリマーであってもよい。コポリマー中の各種モノマーの重量の合計を 100重量部とした場合、アンモニゥム塩モノマーの含有量は、少なすぎると十分な抗 菌性が得られないことから、 1重量部以上が好ましぐ 10重量部以上がより好ましぐ 30重量部以上が最も好まし!/、。  [0043] The polymer compound of the present invention may be a homopolymer of ammonium salt monomers or a copolymer with other monomers. When the total weight of the various monomers in the copolymer is 100 parts by weight, the content of the ammonium salt monomer is too small to obtain sufficient antibacterial properties. More than 30 parts by weight is most preferred!
[0044] 本発明の眼用レンズに用いられる高分子化合物に、アンモニゥム塩モノマー以外 の他のモノマーを共重合する場合のモノマーの例としては、共重合可能であれば特 に制限はなぐ(メタ)アタリロイル基、スチリル基、ァリル基、ビュル基、および他の重 合可能な炭素'炭素不飽和結合を有するモノマーを使用することができる。その例と して、 N—ビュルピロリドン、 N, N—ジメチルアクリルアミド、 N—ビュルホルムアミド、 N—ビュルァセトアミドなどのアミド系モノマー、 2—ヒドロキシェチルメタタリレート、 2 一(2—ヒドロキシエトキシ)ェチルメタタリレートなどの水酸基を有するモノマー、 3—ト リス(トリメチルシロキシ)シリルプロピルメタタリレート、片末端または両末端に (メタ)ァ クリル基を有するポリジメチルシロキサンなどのシリコーン系モノマーなどが挙げられ る。これらのうち、アンモニゥム塩モノマーとの相溶性が得られやすい点からより好ま しいのはアミド系モノマー、水酸基を有するモノマーであり、最も好ましいのは N—ビ ニルピロリドンである。  [0044] Examples of the monomer in the case where the polymer compound used in the ophthalmic lens of the present invention is copolymerized with a monomer other than the ammonium salt monomer are not particularly limited as long as copolymerization is possible (meta-metabolism). ) Monomers having an allyloyl group, a styryl group, a allyl group, a bur group, and other polymerizable carbon'carbon unsaturated bonds can be used. Examples include amide monomers such as N-Buylpyrrolidone, N, N-Dimethylacrylamide, N-Buylformamide, N-Bulucacetamide, 2-Hydroxyethyl methacrylate, and 2 (2-Hydroxyl). Monomers having a hydroxyl group such as ethoxy) ethyl methacrylate, silicone monomers such as 3-tris (trimethylsiloxy) silylpropyl methacrylate, polydimethylsiloxane having a (meth) acryl group at one or both ends And so on. Among these, an amide monomer and a monomer having a hydroxyl group are more preferable because they are easily compatible with an ammonium salt monomer, and N-vinylpyrrolidone is most preferable.
[0045] 本発明の眼用レンズに用いる高分子化合物の分子量は、小さすぎると高分子化合 物が基材力 溶出しやすくなり、大きすぎると高分子化合物のモノマー混合液や含 浸溶液に対する溶解性が低下することから、 1000〜; 100万力 S好ましく、 5000〜50 万がより好ましぐ 10000〜30万が最も好ましい。 [0045] If the molecular weight of the polymer compound used in the ophthalmic lens of the present invention is too small, the polymer compound is likely to elute the substrate, and if it is too large, the polymer compound monomer mixture or a liquid containing it is contained. Since the solubility with respect to the immersion solution is lowered, 1000 to 1 million, preferably S, more preferably 5,000 to 500,000, most preferably 10,000 to 300,000.
[0046] 本発明の眼用レンズに用いられる高分子化合物の含有量は、少なすぎると十分な 抗菌性が得られず、多すぎると十分な透明性が得られないことから、 0. 0;!〜 20重量 %が好ましぐ 0. 5〜; 15重量%がより好ましぐ;!〜 10重量%が最も好ましい。  [0046] If the content of the polymer compound used in the ophthalmic lens of the present invention is too small, sufficient antibacterial properties cannot be obtained, and if it is too large, sufficient transparency cannot be obtained. ! ~ 20% by weight is preferred 0.5 ~; 15% by weight is more preferred;! ~ 10% by weight is most preferred.
[0047] 本発明の眼用レンズにおいては、良好な機械物性が得られ、消毒液や洗浄液に対 する良好な耐性が得られるという意味で、 1分子中に 2個以上の共重合可能な炭素 炭素不飽和結合を有するモノマーを共重合成分として用いることが好ましい。 1分子 中に 2個以上の共重合可能な炭素炭素不飽和結合を有するモノマーの共重合比率 は 0.;!〜 20重量%が好ましぐ 0. 3〜; 15重量%力 り好ましく、 0. 5〜; 10重量%が さらに好ましい。  [0047] In the ophthalmic lens of the present invention, two or more copolymerizable carbons in one molecule are obtained in the sense that good mechanical properties are obtained and good resistance to a disinfecting solution and a cleaning solution is obtained. It is preferable to use a monomer having a carbon unsaturated bond as a copolymerization component. The copolymerization ratio of two or more copolymerizable carbon-carbon unsaturated bonds in one molecule is preferably 0.;! To 20% by weight, preferably 0.3 to 15% by weight, more preferably 0 5 to 10% by weight is more preferable.
[0048] 本発明の眼用レンズは、紫外線吸収剤や色素、着色剤などを含むものでもよ!/、。ま た重合性基を有する紫外線吸収剤や色素、着色剤を共重合した形で含有してもよ!/ヽ [0048] The ophthalmic lens of the present invention may contain an ultraviolet absorber, a pigment, a colorant, and the like! It may also contain UV-absorbers, dyes, and colorants having a polymerizable group in a copolymerized form! / ヽ
Yes
[0049] 本発明の眼用レンズを重合により得る際は、重合をしやすくするために過酸化物や ァゾ化合物に代表される熱重合開始剤や、光重合開始剤を添加することが好ましい 。熱重合を行う場合は、所望の反応温度に対して最適な分解特性を有するものを選 択して使用する。一般的には 10時間半減期温度が 40°C〜120°Cのァゾ系開始剤 および過酸化物系開始剤が好適である。光重合開始剤としてはカルボニル化合物、 過酸化物、ァゾ化合物、硫黄化合物、ハロゲン化合物、および金属塩などを挙げるこ とができる。これらの重合開始剤は単独または混合して用いられ、およそ 1重量%くら いまでの量で使用される。  [0049] When the ophthalmic lens of the present invention is obtained by polymerization, it is preferable to add a thermal polymerization initiator typified by a peroxide or a azo compound or a photopolymerization initiator in order to facilitate polymerization. . When performing thermal polymerization, select one having the optimum decomposition characteristics for the desired reaction temperature. In general, azo initiators and peroxide initiators having a 10-hour half-life temperature of 40 ° C to 120 ° C are suitable. Examples of the photopolymerization initiator include carbonyl compounds, peroxides, azo compounds, sulfur compounds, halogen compounds, and metal salts. These polymerization initiators are used alone or in combination, and are used in an amount of up to about 1% by weight.
[0050] 本発明の眼用レンズを重合により得る際は、重合溶媒を使用することができる。溶 媒としては有機系、無機系の各種溶媒が適用可能であり特に制限はない。例を挙げ れば、水、メタノール、エタノール、プロパノール、 2—プロパノール、ブタノール、 tert ーブタノール、 tert—ァミルアルコール、 3, 7—ジメチルー 3—ォクタノールなどの各 種アルコール系溶剤、ベンゼン、トルエン、キシレンなどの各種芳香族炭化水素系溶 剤、へキサン、ヘプタン、オクタン、デカン、石油エーテル、ケロシン、リグ口イン、パラ フィンなどの各種脂肪族炭化水素系溶剤、アセトン、メチルェチルケトン、メチルイソ ブチルケトンなどの各種ケトン系溶剤、酢酸ェチル、酢酸ブチル、安息香酸メチル、 フタル酸ジォクチル、二酢酸エチレングリコールなどの各種エステル系溶剤、ジェチ ノレエーテル、テトラヒドロフラン、ジォキサン、エチレングリコールジアルキルエーテル 、ジエチレングリコーノレジァノレキノレエーテノレ、トリエチレングリコーノレジァノレキノレエ一 テル、テトラエチレングリコールジアルキルエーテル、ポリエチレングリコールジアルキ ノレエーテル、ポリエチレングリコール ポリプロピレングリコールブロック共重合体、ポ リエチレングリコール ポリプロピレングリコールランダム共重合体などの各種グリコー ルエーテル系溶剤であり、これらは単独あるいは混合して使用することができる。 [0050] When the ophthalmic lens of the present invention is obtained by polymerization, a polymerization solvent can be used. As the solvent, various organic and inorganic solvents are applicable and there is no particular limitation. For example, water, methanol, ethanol, propanol, 2-propanol, butanol, tert-butanol, tert-amyl alcohol, 3,7-dimethyl-3-octanol and other alcohol solvents, benzene, toluene, xylene Various aromatic hydrocarbon solvents such as hexane, heptane, octane, decane, petroleum ether, kerosene, rig in, para Various aliphatic hydrocarbon solvents such as fins, various ketone solvents such as acetone, methyl ethyl ketone and methyl isobutyl ketone, various ester systems such as ethyl acetate, butyl acetate, methyl benzoate, dioctyl phthalate and ethylene glycol diacetate Solvent, Jetino ether, Tetrahydrofuran, Dioxane, Ethylene glycol dialkyl ether, Diethylene glycolino resin quinoleate, Triethylene glycol resin resin, Tetraethylene glycol dialkyl ether, Polyethylene glycol dialkyl ether, Polyethylene Glycol Polypropylene glycol block copolymer, Polyethylene glycol Polypropylene glycol Random copolymer and other glycol ether solvents They can be used alone or in combination.
[0051] 本発明の眼用レンズの重合方法、成形方法としては通常の方法を使用することが できる。たとえば一旦、丸棒や板状に成形し、これを切削加工等によって所望の形状 に加工する方法、モールド重合法、およびスピンキャスト法などである。 [0051] As the polymerization method and molding method for the ophthalmic lens of the present invention, ordinary methods can be used. For example, a method of once forming a round bar or a plate and processing it into a desired shape by cutting or the like, a mold polymerization method, a spin cast method, or the like.
一例として本発明の眼用レンズをモールド重合法により得る場合について、次に説 明する。  As an example, the case where the ophthalmic lens of the present invention is obtained by the mold polymerization method will be described below.
[0052] モノマー組成物を一定の形状を有する 2枚のモールドの空隙に充填する。そして光 重合あるいは熱重合を行ってモールドの形状に賦型する。モールドは樹脂、ガラス、 セラミックス、金属等で製作されているが、光重合の場合は光学的に透明な素材が用 いられ、通常は樹脂またはガラスが使用される。ポリマーを製造する場合には、多く の場合、 2枚の対向するモールドにより空隙が形成されており、その空隙にモノマー 組成物が充填される力 S、モールドの形状やモノマーの性状によってはポリマーに一 定の厚みを与え、かつ、充填したモノマー組成物の液もれを防止する目的を有する ガスケットを併用してもよい。続いて、空隙にモノマー組成物を充填したモールドは、 紫外線のような活性光線を照射される力、、オーブンや液槽に入れて加熱されて、モノ マーを重合する。光重合の後に加熱重合したり、逆に加熱重合後に光重合するなど 、両者を併用する方法もあり得る。光重合の場合は、例えば水銀ランプや捕虫灯を光 源とする紫外線を多く含む光を短時間(通常は 1時間以下)照射するのが一般的であ る。熱重合を行う場合には、室温付近力 徐々に昇温し、数時間ないし数十時間か けて 60°C〜200°Cの温度まで高めていく条件が、ポリマーの光学的な均一性、品位 を保持し、かつ再現性を高めるために好まれる。 [0052] The monomer composition is filled in the space between two molds having a certain shape. Then, photopolymerization or thermal polymerization is performed to shape the mold. The mold is made of resin, glass, ceramics, metal, etc., but in the case of photopolymerization, an optically transparent material is used, and usually resin or glass is used. When a polymer is produced, in many cases, a void is formed by two opposing molds, and the force S that fills the void with the monomer composition S, and depending on the shape of the mold and the properties of the monomer, A gasket having the purpose of giving a constant thickness and preventing leakage of the filled monomer composition may be used in combination. Subsequently, the mold in which the voids are filled with the monomer composition is heated by being put in an oven or a liquid bath with the power to be irradiated with an actinic ray such as ultraviolet rays to polymerize the monomer. There may be a method in which both are used in combination, such as heat polymerization after photopolymerization or conversely photopolymerization after heat polymerization. In the case of photopolymerization, it is common to irradiate light containing a large amount of ultraviolet light using a mercury lamp or insect trap as a light source for a short time (usually 1 hour or less). In the case of thermal polymerization, the condition of gradually increasing the temperature near room temperature and raising the temperature to 60 ° C to 200 ° C over several hours to several tens of hours is the optical uniformity of the polymer, Grade Is preferred in order to maintain and improve reproducibility.
[0053] 本発明の眼用レンズは、抗菌効果を持続させるため、高分子化合物が基材ハイド口 ゲルの網目構造中に分散されている。高分子化合物を基材中に分散させる方法の 例として、ハイド口ゲルの原料モノマーまたは原料マクロモノマー混合液中に高分子 化合物を混合した状態でハイド口ゲルを重合させる方法、ハイド口ゲルを高分子化合 物の溶液中に浸漬して含浸させる方法などが挙げられる。  [0053] In the ophthalmic lens of the present invention, in order to maintain the antibacterial effect, the high molecular compound is dispersed in the network structure of the base hydrated gel. As an example of a method of dispersing a polymer compound in a base material, a method of polymerizing a hide-mouth gel in a state where a polymer compound is mixed in a raw monomer or raw material macromonomer mixture of a hide-mouth gel, Examples include a method of impregnating by impregnating in a solution of a molecular compound.
[0054] ノ、イド口ゲルモノマー混合液中に高分子化合物を混合した状態でハイド口ゲルを重 合させる方法の場合、高分子化合物の含有量は少なすぎると十分な抗菌性が得ら れず、多すぎるとハイド口ゲルの固形分が少なくなることから 0· ;!〜 20%が好ましぐ 0. 5〜; 15%がより好ましぐ;!〜 10%がもっとも好ましい。  [0054] In the case of a method in which a high molecular weight compound is mixed in a state where a high molecular compound is mixed in a liquid mixture of anodic gel monomer, sufficient antibacterial properties cannot be obtained if the content of the high molecular compound is too small. When the amount is too large, the solid content of the gel is reduced. 0 to 20% is preferable 0.5 to 15% is more preferable; 10 to 10% is most preferable.
[0055] ハイド口ゲルを高分子化合物の溶液中に浸漬して含浸させる方法の場合、高分子 化合物の溶液に使用する溶媒は有機系、無機系の各種溶媒が適用可能であり特に 制限はない。例を挙げれば、水、メタノール、エタノール、プロパノール、 2—プロパノ 一ノレ、ブタノール、 tert ブタノール、 tert ァミルアルコール、 3, 7—ジメチルー 3 ーォクタノールなどの各種アルコール系溶剤、ベンゼン、トルエン、キシレンなどの各 種芳香族炭化水素系溶剤、へキサン、ヘプタン、オクタン、デカン、石油エーテル、 ケロシン、リグ口イン、パラフィンなどの各種脂肪族炭化水素系溶剤、アセトン、メチル ェチルケトン、メチルイソブチルケトンなどの各種ケトン系溶剤、酢酸ェチル、酢酸ブ チル、安息香酸メチル、フタル酸ジォクチル、二酢酸エチレングリコールなどの各種 エステル系溶剤、ジェチルエーテル、テトラヒドロフラン、ジォキサン、エチレングリコ 一ノレジァノレキノレエーテノレ、ジエチレングリコーノレジァノレキノレエーテノレ、トリエチレング リコールジアルキルエーテル、テトラエチレングリコールジアルキルエーテル、ポリエ チレングリコ一ノレジァノレキノレエーテノレ、ポリエチレングリコ一ノレ ポリプロピレングリコ 一ノレブロック共重合体、ポリエチレングリコール ポリプロピレングリコールランダム共 重合体などの各種ダリコールエーテル系溶剤であり、これらは単独あるいは混合して 使用すること力できる。これらのうち、最も好ましいのは水である。  [0055] In the case of the method of immersing and impregnating a hydrated gel in a polymer compound solution, various organic and inorganic solvents can be applied to the polymer compound solution, and there is no particular limitation. . Examples include water, methanol, ethanol, propanol, 2-propanol monoole, butanol, tert-butanol, tert-amyl alcohol, various alcohol solvents such as 3,7-dimethyl-3-octanol, benzene, toluene, xylene, etc. Various aromatic hydrocarbon solvents, hexane, heptane, octane, decane, petroleum ether, kerosene, rigging, paraffin and other aliphatic hydrocarbon solvents, acetone, methyl ethyl ketone, methyl isobutyl ketone and other ketones Solvents, ethyl acetate, butylacetate, methyl benzoate, dioctyl phthalate, ethylene glycol diacetate, and other ester solvents, jetyl ether, tetrahydrofuran, dioxane, ethylene glycol monoresidanolenoquine ethere, diethylene Glico Resinolequinoleateol, triethylene glycol dialkyl ether, tetraethylene glycol dialkyl ether, polyethylene glycol monoresinoleateolene, polyethylene glycol mononore polypropylene glycol mononore block copolymer, polyethylene glycol polypropylene glycol random co These are various Daricol ether solvents such as polymers, and these can be used alone or in combination. Of these, water is most preferred.
[0056] 高分子化合物の水溶液の濃度は、低すぎると十分な抗菌性が得られず、高すぎる と過剰の高分子化合物の洗浄が必要になる可能性があることから、 0. ;!〜 30%が好 ましぐ 0. 5〜20%がより好ましぐ;!〜 10%が最も好ましい。 [0056] If the concentration of the aqueous solution of the polymer compound is too low, sufficient antibacterial properties cannot be obtained, and if it is too high, it may be necessary to wash the excess polymer compound. 30% preferred 0.5 to 20% is more preferred;! To 10% is most preferred.
[0057] 本発明の眼用レンズは、種々の方法で改質処理を行うことができる。表面の水濡れ 性を向上させる改質処理を行うことが好ましい。  [0057] The ophthalmic lens of the present invention can be modified by various methods. It is preferable to perform a modification treatment that improves the wettability of the surface.
[0058] 具体的な改質方法としては、電磁波 (光を含む)照射、プラズマ照射、蒸着およびス パッタリングなどのケミカルベーバーデポジション処理、加熱、塩基処理、酸処理、そ の他適当な表面処理剤の使用、およびこれらの組み合わせを挙げることができる。こ れらの改質手段の中で、簡便であり好ましいのは塩基および酸処理である。  [0058] Specific reforming methods include electromagnetic wave (including light) irradiation, plasma irradiation, chemical vapor deposition treatment such as vapor deposition and sputtering, heating, base treatment, acid treatment, and other suitable surfaces. Mention may be made of the use of treatment agents and combinations thereof. Among these reforming means, simple and preferred are base and acid treatments.
[0059] 塩基処理または酸処理の一例としては、眼用レンズを塩基性または酸性溶液に接 触させる方法、眼用レンズを塩基性または酸性ガスに接触させる方法等が挙げられ る。そのより具体的な方法としては、例えば塩基性または酸性溶液に眼用レンズを浸 漬する方法、眼用レンズに塩基性または酸性溶液または塩基性または酸性ガスを噴 霧する方法、眼用レンズに塩基性または酸性溶液をヘラ、刷毛等で塗布する方法、 眼用レンズに塩基性または酸性溶液をスピンコート法やディップコート法などを挙げ ること力 Sできる。最も簡便に大きな改質効果が得られる方法は、眼用レンズを塩基性 または酸性溶液に浸漬する方法である。  [0059] Examples of the base treatment or acid treatment include a method of contacting an ophthalmic lens with a basic or acidic solution, a method of contacting an ophthalmic lens with a basic or acidic gas, and the like. More specific methods include, for example, a method in which an ophthalmic lens is immersed in a basic or acidic solution, a method in which a basic or acidic solution or basic or acidic gas is sprayed on an ophthalmic lens, or an ophthalmic lens. For example, a method of applying a basic or acidic solution with a spatula, a brush or the like, and applying a basic or acidic solution to an ophthalmic lens by a spin coating method or a dip coating method can be cited. The most simple method for obtaining a great modification effect is a method of immersing an ophthalmic lens in a basic or acidic solution.
[0060] 眼用レンズを塩基性または酸性溶液に浸漬する際の温度は特に限定されないが、 通常 50°C〜300°C程度の温度範囲内で行われる。作業性を考えれば 10°C〜 150°Cの温度範囲がより好ましぐ - 5°C〜60°Cが最も好ましレ、。  [0060] The temperature at which the ophthalmic lens is immersed in a basic or acidic solution is not particularly limited, but is usually within a temperature range of about 50 ° C to 300 ° C. Considering workability, a temperature range of 10 ° C to 150 ° C is more preferable-5 ° C to 60 ° C is most preferable.
眼用レンズを塩基性または酸性溶液に浸漬する時間につ!/、ては、温度によっても最 適時間は変化する力 一般には 0.;!〜 100時間が好ましぐ 0. 3〜24時間以内がよ り好ましぐ 0. 5〜; 12時間以内が最も好ましい。接触時間が短すぎると十分な処理効 果が得られず、接触時間が長すぎると、作業性および生産性が悪くなるば力、りでなく 、酸素透過性の低下や機械物性の低下などの悪影響が出る場合がある。  The time when the ophthalmic lens is immersed in a basic or acidic solution! /, The force that changes the optimum time depending on the temperature Generally 0.;! ~ 100 hours are preferred 0.3 ~ 24 hours Is more preferable within 0.5; most preferably within 12 hours. If the contact time is too short, a sufficient treatment effect cannot be obtained, and if the contact time is too long, if workability and productivity are deteriorated, not only the power but also the oxygen permeability and mechanical properties are reduced. There may be adverse effects.
[0061] 塩基としてはアルカリ金属水酸化物、アルカリ土類金属水酸化物、各種炭酸塩、各 種ホウ酸塩、各種リン酸塩、アンモニア、各種アンモニゥム塩、各種アミン類およびポ リエチレンィミン、ポリビュルァミン等の高分子量塩基などが使用可能である。これら の中では、低価格であることおよび処理効果が大きいことからアルカリ金属水酸化物 が最も好ましい。 [0062] 酸としては硫酸、リン酸、塩酸、硝酸等の各種無機酸、酢酸、ギ酸、安息香酸、フエ ノール等の各種有機酸、およびポリアクリル酸、ポリスチレンスルホン酸などの各種高 分子量酸が使用可能である。これらの中では、処理効果が大きく他の物性への悪影 響が少ないことから高分子量酸が好ましぐそれらのうち、酸性度や溶解性の点でポ リアクリル酸が最も好ましい。。 [0061] Examples of the base include alkali metal hydroxides, alkaline earth metal hydroxides, various carbonates, various borates, various phosphates, ammonia, various ammonium salts, various amines and polyethyleneimine, High molecular weight bases such as polybulamine can be used. Of these, alkali metal hydroxides are most preferred because of their low cost and great treatment effect. [0062] Examples of acids include various inorganic acids such as sulfuric acid, phosphoric acid, hydrochloric acid, and nitric acid, various organic acids such as acetic acid, formic acid, benzoic acid, and phenol, and various high molecular weight acids such as polyacrylic acid and polystyrene sulfonic acid. It can be used. Among these, polyacrylic acid is most preferable from the viewpoint of acidity and solubility among those preferred to high molecular weight acids because they have a large treatment effect and little adverse effect on other physical properties. .
[0063] 塩基性または酸性溶液の溶媒としては、無機、有機の各種溶媒が使用できる。例 えば、水、メタノール、エタノール、プロパノール、 2—プロパノーノレ、ブタノール、ェチ レングリコーノレ、ジエチレングリコーノレ、トリエチレングリコーノレ、テトラエチレングリコー ノレ、ポリエチレングリコール、グリセリンなどの各種アルコール類、ベンゼン、トルエン 、キシレンなどの各種芳香族炭化水素、へキサン、ヘプタン、オクタン、デカン、石油 エーテル、ケロシン、リグ口イン、パラフィンなどの各種脂肪族炭化水素、アセトン、メ チルェチルケトン、メチルイソブチルケトンなどの各種ケトン類、酢酸ェチル、酢酸ブ チル、安息香酸メチル、フタル酸ジォクチルなどの各種エステル類、ジェチルエーテ ノレ、テトラヒドロフラン、ジォキサン、エチレングリコールジアルキルエーテル、ジェチ レングリコーノレジァノレキノレエーテノレ、 トリエチレングリコーノレジァノレキノレエーテノレ、テト ラエチレングリコーノレジァノレキノレエーテノレ、ポリエチレングリコーノレジァノレキノレエーテ ルなどの各種エーテル類、ジメチルホルムアミド、ジメチルァセトアミド、 N—メチルー 2—ピロリドン、ジメチルイミダゾリジノン、へキサメチルホスホリックトリアミド、ジメチル スルホキシドなどの各種非プロトン性極性溶媒、塩化メチレン、クロ口ホルム、ジクロロ ェタン、トリクロロェタン、トリクロロエチレンなどのハロゲン系溶媒、およびフロン系溶 媒などである。中でも経済性、取り扱いの簡便さ、および化学的安定性などの点で水 が最も好ましい。溶媒としては、 2種類以上の物質の混合物も使用可能である。  [0063] As the solvent of the basic or acidic solution, various inorganic and organic solvents can be used. For example, water, methanol, ethanol, propanol, 2-propanol, butanol, ethylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, polyethylene glycol, glycerol and other alcohols, benzene, toluene, xylene Various aromatic hydrocarbons such as hexane, heptane, octane, decane, petroleum ether, kerosene, lignin, paraffin and other aliphatic hydrocarbons, acetone, methyl ethyl ketone, methyl isobutyl ketone and other ketones, acetic acid Various esters such as ethyl acetate, butylacetate, methyl benzoate, dioctyl phthalate, etc., jetyl ether, tetrahydrofuran, dioxane, ethylene glycol dialkyl ether, ethylene glycol Various ethers such as ethylene glycolino resinate, triethylene glycolino resinate, and ethylene ethylene glycolino resin. Various aprotic polar solvents such as dimethylformamide, dimethylacetamide, N-methyl-2-pyrrolidone, dimethylimidazolidinone, hexamethylphosphoric triamide, dimethyl sulfoxide, methylene chloride, chloroform, dichloroethane, Halogen solvents such as trichloroethane and trichlorethylene, and fluorocarbon solvents. Of these, water is most preferable from the viewpoints of economy, ease of handling, chemical stability, and the like. As the solvent, a mixture of two or more substances can be used.
[0064] 本発明にお!/、て使用される塩基性または酸性溶液は、塩基性または酸性物質およ び溶媒以外の成分を含んでレ、てもよレ、。  [0064] The basic or acidic solution used in the present invention may contain a basic or acidic substance and components other than the solvent.
[0065] 眼用レンズは、塩基処理または酸処理の後、洗浄により塩基性または酸性物質を 除くこと力 Sでさる。  [0065] The ophthalmic lens is treated with a force S to remove a basic or acidic substance by washing after the base treatment or the acid treatment.
[0066] 洗浄溶媒としては、無機、有機の各種溶媒が使用できる。例えば、水、メタノーノレ、 エタノーノレ、プロノ ノーノレ、 2—プロノ ノーノレ、ブタノーノレ、エチレングリコーノレ、ジェ チレングリコーノレ、トリエチレングリコーノレ、テトラエチレングリコーノレ、ポリエチレングリ コーノレ、グリセリンなどの各種アルコール類、ベンゼン、トルエン、キシレンなどの各種 芳香族炭化水素、へキサン、ヘプタン、オクタン、デカン、石油エーテル、ケロシン、リ グロイン、ノ ラフィンなどの各種脂肪族炭化水素、アセトン、メチルェチルケトン、メチ ルイソブチルケトンなどの各種ケトン類、酢酸ェチル、酢酸ブチル、安息香酸メチル、 フタル酸ジォクチルなどの各種エステル類、ジェチルエーテル、テトラヒドロフラン、ジ ォキサン、エチレングリコールジアルキルエーテル、ジエチレングリコールジアルキル エーテル、トリエチレングリコールジアルキルエーテル、テトラエチレングリコールジァ ノレキルエーテル、ポリエチレングリコールジアルキルエーテルなどの各種エーテル類 、ジメチルホルムアミド、ジメチルァセトアミド、 N—メチルー 2—ピロリドン、ジメチルイ ミダゾリジノン、へキサメチルホスホリックトリアミド、ジメチルスルホキシドなどの各種非 プロトン性極性溶媒、塩化メチレン、クロ口ホルム、ジクロロェタン、トリクロロェタン、ト リクロロエチレンなどのハロゲン系溶媒、およびフロン系溶媒などである。 [0066] As the cleaning solvent, various inorganic and organic solvents can be used. For example, water, methanol, ethanol, prono, 2-prono, butanol, ethylene glycol, Tylene glycol, triethylene glycol, tetraethylene glycol, polyethylene glycol, various alcohols such as glycerin, various aromatic hydrocarbons such as benzene, toluene, xylene, hexane, heptane, octane, decane, petroleum ether, Various aliphatic hydrocarbons such as kerosene, ligroin and norafine, various ketones such as acetone, methyl ethyl ketone and methyl isobutyl ketone, various esters such as ethyl acetate, butyl acetate, methyl benzoate and dioctyl phthalate , Jetyl ether, tetrahydrofuran, dioxane, ethylene glycol dialkyl ether, diethylene glycol dialkyl ether, triethylene glycol dialkyl ether, tetraethylene glycol dialkyl ether , Various ethers such as polyethylene glycol dialkyl ether, various aprotic polar solvents such as dimethylformamide, dimethylacetamide, N-methyl-2-pyrrolidone, dimethylimidazolidinone, hexamethylphosphoric triamide, dimethyl sulfoxide, chloride Halogen solvents such as methylene, chloroform, dichloroethane, trichloroethane, trichloroethylene, and chlorofluorocarbon solvents.
[0067] 洗浄溶媒としては、 2種類以上の溶媒の混合物を使用することもできる。洗浄溶媒 は、溶媒以外の成分、例えば無機塩類、界面活性剤、および洗浄剤を含有してもよ い。 [0067] As the cleaning solvent, a mixture of two or more kinds of solvents may be used. The cleaning solvent may contain components other than the solvent, such as inorganic salts, surfactants, and cleaning agents.
[0068] 該改質処理は、眼用レンズ全体に対して行ってもよぐ例えば表面のみに行うなど 眼用レンズの一部のみに行ってもよい。表面のみに改質処理を行った場合には眼用 レンズ全体の性質を大きく変えることなく表面の水濡れ性のみを向上させることができ 本発明のポリマーを用いてなる眼用レンズの表面の水濡れ性を向上させる他の方法 として、重合時のモノマー混合液中に親水性ポリマーを加えた状態で重合させ、眼 用レンズに親水性ポリマーを保持させて表面の水濡れ性を向上させる内部湿潤剤法 力 S挙げられる。内部湿潤剤として用いる親水性ポリマーの例としては、ポリビュルピロ リドンなどのポリビュル環状アミド類、ポリビュルイミダゾールなどのポリビュル環状アミ ン類、ポリ N, N—ジメチルアクリルアミドなどのポリアクリルアミド類、ポリビュルアルコ ールなどのポリアルコール類、ポリアクリル酸などのポリカルボン酸類、ポリエチレング リコール類、これらの混合物、コポリマーなどを挙げることができる。これらのうち、眼 用レンズ表面の水濡れ性向上の点で最も好ましいのはポリビュルピロリドンである。 [0068] The modification treatment may be performed on the entire ophthalmic lens, or may be performed only on a part of the ophthalmic lens, for example, only on the surface. When only the surface is modified, only the water wettability of the surface can be improved without greatly changing the properties of the entire ophthalmic lens, and the surface water of the ophthalmic lens using the polymer of the present invention can be improved. As another method to improve wettability, internal wettability is achieved by polymerizing the monomer mixture at the time of polymerization with a hydrophilic polymer added, and retaining the hydrophilic polymer in the ophthalmic lens to improve the surface water wettability. Pharmacological power S Examples of hydrophilic polymers used as internal wetting agents include polybulu cyclic amides such as polybulurpyrrolidone, polybulu cyclic amines such as polybutimidazole, polyacrylamides such as poly N, N-dimethylacrylamide, and polybular alcohol. And polyalcohols such as polyacrylic acid, polycarboxylic acids such as polyacrylic acid, polyethylene glycols, mixtures thereof, and copolymers. Of these, the eyes Most preferred from the viewpoint of improving the wettability of the lens surface is polybulurpyrrolidone.
[0069] 本発明の眼用レンズの酸素透過性は、低すぎると、特に連続装用時に酸素不足に よる眼障害が起こり、高くしょうとしすぎると他の眼用レンズに必要とされる諸物性の低 下を招くことから、酸素透過係数 70 X 10— U〜500 X 10— u(cm2/sec)mLO /(mL -h [0069] If the oxygen permeability of the ophthalmic lens of the present invention is too low, eye damage occurs due to lack of oxygen especially during continuous wear, and if it is too high, various physical properties required for other ophthalmic lenses are obtained. Oxygen permeability coefficient 70 X 10— U to 500 X 10— u (cm 2 / sec) mLO / (mL -h
2  2
Pa)が好ましい。  Pa) is preferred.
[0070] 本発明の眼用レンズの抗菌性は、緑膿菌で 3サンプルの菌数を測定した場合、培 養後の菌数の 3回の平均値が、培養前の初期菌数の 3回の平均値の 4倍以内であれ ば増殖なしとみなし、抗菌効果があると判断する。より好ましくはコントロールの菌数 の平均値の 10%以下であり、最も好ましくはコントロールの菌数の 1 %以下である。  [0070] The antibacterial properties of the ophthalmic lens of the present invention are as follows. When the number of bacteria in 3 samples was measured with Pseudomonas aeruginosa, the average of the number of bacteria after cultivation was 3 times the initial number of bacteria before culture. If it is within 4 times the average number of times, it is considered that there is no growth and is judged to have antimicrobial effect. More preferably, it is 10% or less of the average number of control bacteria, and most preferably 1% or less of the number of control bacteria.
[0071] 本発明のポリマーは、コンタクトレンズ、眼内レンズ、人工角膜などの眼用レンズとし て特に好適である。  [0071] The polymer of the present invention is particularly suitable as an ophthalmic lens such as a contact lens, an intraocular lens, and an artificial cornea.
実施例  Example
[0072] 以下、実施例により本発明を具体的に説明するが、本発明はこれによって限定され るものではない。  [0072] Hereinafter, the present invention will be specifically described by way of examples, but the present invention is not limited thereto.
[0073] 実施例 1 [0073] Example 1
下記式 (yl)  The following formula (yl)
[0074] [化 10] [0074] [Chemical 10]
Figure imgf000020_0001
Figure imgf000020_0001
[0075] で表されるシリコーン化合物(28. 8重量部)、 N, N—ジメチルアクリルアミド(35. 5 重量部)、下記式 (y2) [0075] a silicone compound (28.8 parts by weight), N, N-dimethylacrylamide (35.5 parts by weight), the following formula (y2)
[0076] [化 11] [0076] [Chemical 11]
Figure imgf000021_0001
Figure imgf000021_0001
[0077] で表される片末端がメタクリル化されたポリジメチルシロキサン(分子量約 1000、 28. [0077] A polydimethylsiloxane having a molecular weight of about 1000, 28.
8重量部)、 2—ヒドロキシェチルメタタリレート(3· 8重量部)、トリ(エチレングリコール )ジメタタリレート(3· 0重量部)、分子内にアンモニゥム基を有するモノマー単位を有 する高分子化合物(分子量約 40000、 PVP /ビュルメチルイミダゾリゥムクロリド = 9 5/5、 6重量部)、光開始剤ィルガキュア 1850 (1. 0重量部)、 3, 7—ジメチルー 3 ーォクタノール (46重量部)を混合し撹拌した。本組成の N/OH比を計算すると 0. 24となる。このモノマー混合物をアルゴン雰囲気下で脱気した。窒素雰囲気下のグロ ーブボックス中で 10cm角、厚さ 3mmのガラス板 2枚(うち 1枚には剥離しやすいよう にアルミシールを貼付)の間に、厚さ 100 mのパラフィルムの中央部を切り抜いたも のを 2枚スぺーサ一として挟み、そこにモノマー混合物を流し込んで、光照射 (東芝 F L6D蛍光灯、 8. 4キロルクス、 15分間)により板間重合してフィルム状サンプルを得 た。  8 parts by weight), 2-hydroxyethyl methacrylate (3 · 8 parts by weight), tri (ethylene glycol) dimetatalylate (3 · 30 parts by weight), and a monomer unit having an ammonium group in the molecule. Molecular compound (Molecular weight approx. 40000, PVP / Burmethylimidazolium chloride = 9 5/5, 6 parts by weight), Photoinitiator Irgacure 1850 (1.0 part by weight), 3, 7-dimethyl-3-octanol (46 parts by weight) ) Were mixed and stirred. The N / OH ratio of this composition is calculated to be 0.24. The monomer mixture was degassed under an argon atmosphere. Place the center of a 100-m-thick parafilm between two 10-cm square and 3-mm-thick glass plates in a nitrogen atmosphere (one of them is affixed with an aluminum seal to make it easier to peel off). Put the cut out as a two-sheet spacer, pour the monomer mixture into it, and polymerize between plates by light irradiation (Toshiba F L6D fluorescent lamp, 8.4 kilolux, 15 minutes) to obtain a film sample It was.
[0078] 得られたフィルム状サンプルを、水中で超音波を 20分間あててガラス板から剥離し 、 60%IPA水溶液に 60°Cで一晚浸漬し、さらに 80%IPA水溶液に 60°C、 2時間浸 漬して残存モノマーなどの不純物を抽出し、 50%IPA水溶液、 25%水溶液、水と段 階的に IPA濃度を下げた液におよそ 30分ずっ浸漬して水和した。 200mLガラス瓶 中のホウ酸緩衝液(ρΗ7· ;!〜 7. 3)に浸漬し、該ガラス瓶をオートクレーブに入れ、 1 21°Cで 30分間煮沸処理を行った。放冷後、フィルム状サンプルをガラス瓶から取り 出し、ホウ酸緩衝液 (ρΗ7· ;!〜 7. 3)に浸漬した。得られたフィルム状サンプルを 3c m角に切り出して抗菌性評価用サンプルとした。  [0078] The obtained film-like sample was peeled from the glass plate by applying ultrasonic waves in water for 20 minutes, immersed in a 60% IPA aqueous solution at 60 ° C, and further immersed in an 80% IPA aqueous solution at 60 ° C. Impregnation such as residual monomer was extracted by immersion for 2 hours, and hydrated by immersing in 50% IPA aqueous solution, 25% aqueous solution, and water with gradually decreasing IPA concentration for approximately 30 minutes. It was immersed in a borate buffer solution (ρΗ7 ·;!-7.3) in a 200 mL glass bottle, and the glass bottle was placed in an autoclave and boiled at 121 ° C. for 30 minutes. After allowing to cool, the film-like sample was taken out from the glass bottle and immersed in a borate buffer (ρΗ7 · !!-7.3). The obtained film-like sample was cut into 3 cm squares to obtain antibacterial evaluation samples.
[0079] 実施例 1で得られたサンプルを 40°C、 16時間真空乾燥を行った後、 2gとり、蒸留 水中で超音波洗浄を 30分間行った後、 2—プロパノールに浸漬して 60°Cで 24時間 加熱した。抽出液からエバポレータを用いて溶媒を留去し、さらに真空ポンプで減圧 して完全に残存溶媒を除去して重量を測定したところ、抽出物は 56. 9mgであった。 また、赤外線吸収スペクトルから、この抽出物は PVP /ビュルメチルイミダゾリゥムク 口リド共重合体であることがわ力 た。このこと力 、実施例 1のサンプル中には分子 内にアンモニゥム基を有するモノマー単位を有する高分子化合物が分散されて!/、な いことが確認できた。 [0079] After the sample obtained in Example 1 was vacuum-dried at 40 ° C for 16 hours, 2 g was taken, ultrasonically washed in distilled water for 30 minutes, then immersed in 2-propanol at 60 ° Heated at C for 24 hours. Evaporate the solvent from the extract using an evaporator, and then reduce the pressure using a vacuum pump. Then, when the residual solvent was completely removed and the weight was measured, the extract was 56.9 mg. In addition, from the infrared absorption spectrum, this extract was found to be a PVP / Burmethyl imidazolium glycide copolymer. From this, it was confirmed that the polymer of Example 1 was not dispersed with a polymer compound having a monomer unit having an ammonium group in the molecule.
[0080] 合成例 1 [0080] Synthesis Example 1
50mLナスフラスコに N ビュルイミダゾール(4. 71g、 50mmol)、ヨウ化 n オタ チノレ(12. 01g、 50mmol)、 2, 6 ジ一 t ブチル 4 メチルフエノール(BHT、 0 . 1672g)を加え、 65°Cで 14時間加熱した。反応後、シリカゲル 90gを用い、クロロホ ノレム/メタノーノレ = 50/1 (360mL)→30/l (360mL)→20/l (360mL)→10 /l (180mL)→5/l (180mUを溶出液として用いてカラム精製した。 TLCで目的 物のスポットが含まれるフラクションを集め、エバポレータで溶媒を留去して、下記式( xl)で表される黄色オイル状のアンモニゥム塩モノマーを得た。  To a 50 mL eggplant flask, add N-Buylimidazole (4.71 g, 50 mmol), iodinated notachinole (12. 01 g, 50 mmol), 2,6-di-tert-butyl 4-methylphenol (BHT, 0.1672 g), 65 ° Heated at C for 14 hours. After the reaction, 90 g of silica gel was used, and chloroform / methanolate = 50/1 (360 mL) → 30 / l (360 mL) → 20 / l (360 mL) → 10 / l (180 mL) → 5 / l (180 mU as eluent) The fraction containing the target spot was collected by TLC, and the solvent was distilled off by an evaporator to obtain a yellow oily ammonium salt monomer represented by the following formula (xl).
[0081] [化 12] [0081] [Chemical 12]
Figure imgf000022_0001
Figure imgf000022_0001
(xl) 合成例 2 (xl) Synthesis example 2
上記合成例 1で得られた式 (xl)で表されるモノマー(lg)、 3, 7 ジメチルー 3— ォクタノール(lg)、光開始剤ィルガキュア 1850 (0. 02g)を混合し、撹拌した。この モノマー混合物をアルゴン雰囲気下で脱気し、窒素雰囲気下のグローブボックス中 で直径 5cmのシャーレに流し込んだ。光照射(東芝 FL6D蛍光灯、 8. 4キロルクス、 15分間)を行った後、なるべく少量のメタノールに溶解し、 500mLの酢酸ェチル中 に撹拌しながら滴下後、 5°Cで 3時間静置した。ろ過して得られた固形分を少量の酢 酸ェチルで洗い、デシケータ中で減圧することにより溶媒を留去して、上記式 (xl)で 表されるモノマーのホモポリマーであるポリ(ビュルォクチルイミダゾリウムョージド)を 得た。 The monomer (lg) represented by the formula (xl) obtained in Synthesis Example 1 above, 3,7 dimethyl-3-octanol (lg), and photoinitiator Irgacure 1850 (0.02 g) were mixed and stirred. This monomer mixture was degassed under an argon atmosphere and poured into a petri dish having a diameter of 5 cm in a glove box under a nitrogen atmosphere. Light irradiation (Toshiba FL6D fluorescent lamp, 8.4 kilolux, 15 minutes), dissolved in as little methanol as possible, dropped into 500 mL of ethyl acetate with stirring, and allowed to stand at 5 ° C for 3 hours. The solid content obtained by filtration was washed with a small amount of ethyl acetate, and the solvent was distilled off by reducing the pressure in a desiccator. Poly (Buluo), which is a homopolymer of the monomer represented by the above formula (xl). (Cutyl imidazolium iodide) was obtained.
[0083] 実施例 2 [0083] Example 2
モノマー糸且成を、式 (yl)で表されるシリコーン化合物(23重量部)、下記式 (y3) [0084] [化 13]  The monomer yarn is formed by a silicone compound represented by the formula (yl) (23 parts by weight), the following formula (y3) [0084] [Chemical Formula 13]
Figure imgf000023_0001
Figure imgf000023_0001
[0085] で表されるシリコーン化合物(35重量部)、 N, N—ジメチルアクリルアミド(28重量部 )、ポリ(ビュルピロリドン)(K— 90、 8重量部)、 2—ヒドロキシェチルメタタリレート(12 重量部)、トリ(エチレングリコール)ジメタタリレート(1重量部)、両末端カ^タクリル化 されたポリジメチルシロキサン (信越化学 X— 22— 164Α、 1重量部)、上記合成例 2 で得られたポリ(ビュルォクチルイミダゾリウムョージド) (3. 7重量部)、光開始剤ィノレ ガキュア 1850 (1重量部)、 3, 7—ジメチルー 3—ォクタノール(14重量部)の混合物 に変えて実施例 1と同様の重合、後処理を行い、抗菌性評価用サンプルを得た。 [0085] A silicone compound represented by (35 parts by weight), N, N-dimethylacrylamide (28 parts by weight), poly (bulurpyrrolidone) (K-90, 8 parts by weight), 2-hydroxyethyl methacrylate (12 parts by weight), tri (ethylene glycol) dimetatalylate (1 part by weight), polydimethylsiloxane catalyzed at both ends (Shin-Etsu Chemical X-22-164Α, 1 part by weight), in Synthesis Example 2 above In a mixture of the obtained poly (buluoctylimidazolium iodide) (3.7 parts by weight), photoinitiator Inore Gacure 1850 (1 part by weight), 3,7-dimethyl-3-octanol (14 parts by weight) The sample was subjected to the same polymerization and post-treatment as in Example 1 to obtain a sample for antibacterial evaluation.
[0086] 実施例 3〜4  [0086] Examples 3-4
ポリ(ビュルォクチルイミダゾリウムョージド)の使用量を下の表 1のように変える以外 は実施例 2の方法にしたがって、重合、後処理を行い、抗菌性評価用サンプルを得 た。  A sample for antibacterial evaluation was obtained by performing polymerization and post-treatment according to the method of Example 2 except that the amount of poly (buluoctylimidazolium iodide) was changed as shown in Table 1 below.
[0087] [表 1] 表 1  [0087] [Table 1] Table 1
使用重 Ν Ζ Ο Η比  Usage weight Ν Ζ Η Ratio
実施例 2 3 . 8 0 . 0 5  Example 2 3 .8 0 .0 5
実施例 3 5 . 0 0 . 0 7  Example 3 5 .0 0 .0 7
実施例 4 1 0 . 0 0 . 1 4 [0088] 比較例 1 Example 4 1 0. 0 0. 1 4 [0088] Comparative Example 1
モノマー混合液中に高分子化合物を加えない以外は実施例 1と同様にしてフィル ム状サンプルを得た。 3cm角に切り出して抗菌性評価用サンプルとした。  A film sample was obtained in the same manner as in Example 1 except that the polymer compound was not added to the monomer mixture. It was cut into 3 cm square and used as an antibacterial evaluation sample.
[0089] 比較例 1で得られたサンプルを 40°C、 16時間真空乾燥を行った後、 2gとり、蒸留 水中で超音波洗浄を 30分間行った後、 2 プロパノールに浸漬して 60°Cで 24時間 加熱した。抽出液からエバポレータを用いて溶媒を留去し、さらに真空ポンプで減圧 して完全に残存溶媒を除去して重量を測定したところ、抽出物は 0. lmgであった。 また、溶媒をメタノール、エタノール、トルエン、へキサン、アセトン、メチルェチルケト ン、酢酸ェチル、酢酸ブチル、テトラヒドロフラン、ジメチルスルホキシドに変更して抽 出を行ったが、いずれもサンプルの乾燥重量の 0. 1重量%以上の抽出物が抽出さ れることはなかった。  [0089] After the sample obtained in Comparative Example 1 was vacuum-dried at 40 ° C for 16 hours, 2 g was taken, ultrasonically washed in distilled water for 30 minutes, and then immersed in 2 propanol at 60 ° C. For 24 hours. When the solvent was distilled off from the extract using an evaporator and the pressure was reduced with a vacuum pump to completely remove the remaining solvent and the weight was measured, the extract was 0.1 mg. In addition, extraction was carried out by changing the solvent to methanol, ethanol, toluene, hexane, acetone, methyl ethyl ketone, ethyl acetate, butyl acetate, tetrahydrofuran, or dimethyl sulfoxide, all of which were 0.1 weight of the dry weight of the sample. % Extract was not extracted.
[0090] 比較例 2  [0090] Comparative Example 2
比較例 1で得られたフィルム状サンプルを 50mLスクリュー管に入れ、 1. 7%PVP /ポリメチルビ二ルイミダゾリゥムクロリド(95/5)水溶液に室温で 16時間浸漬した。  The film-like sample obtained in Comparative Example 1 was placed in a 50 mL screw tube and immersed in an aqueous solution of 1.7% PVP / polymethylvinylimidazolium chloride (95/5) at room temperature for 16 hours.
[0091] 抗菌評価 [0091] Antibacterial evaluation
実施例 1〜4で得られたフィルム状サンプルを 3枚用意し、 JIS Z 2801 : 2000「抗 菌加工製品 抗菌性試験方法'抗菌効果」 5. 2 プラスチック製品などの試験方法 に基づき、コンタクトレンズ使用時にみられる代表的な細菌の一つである緑膿菌(Pse udomonas aeruginosa NBRC 13275)をフィルム状サンプルに接種し、接種し た直後の菌数 (初期菌数)および 35°C、 24時間後の菌数をカウントして抗菌評価を 行った。その結果は下表 2および 3の通りであり、高分子化合物を加えずに重合した 比較例 1で得られたフィルム状サンプルでは初期菌数と比較して増殖が見られたの に対し、実施例 1で得られたフィルム状サンプルでは初期菌数と比較して 1桁の減少 1S また、実施例 2〜4では 5桁の減少が見られ、十分な抗菌性を示した。  Prepare three film-like samples obtained in Examples 1 to 4, JIS Z 2801: 2000 “Antimicrobial Processed Products Antibacterial Test Method 'Antimicrobial Effect” 5.2 Contact lenses based on test methods for plastic products Pseudomonas aeruginosa NBRC 13275, one of the typical bacteria seen at the time of use, is inoculated into a film sample, the number of bacteria immediately after inoculation (initial number of bacteria) and 35 ° C, 24 hours Antibacterial evaluation was performed by counting the number of later bacteria. The results are shown in Tables 2 and 3 below. The film-like sample obtained in Comparative Example 1 polymerized without adding a polymer compound showed growth compared to the initial number of bacteria. The film-like sample obtained in Example 1 showed a 1-digit decrease compared to the initial number of bacteria 1S. In addition, Examples 2-4 showed a 5-digit decrease, indicating sufficient antibacterial properties.
[0092] [表 2] 表 2 [0092] [Table 2] Table 2
測定 1 測定 2 測定 3 平均  Measurement 1 Measurement 2 Measurement 3 Average
初期菌数 2.60 X 105 2.80 X 105 2.40 X 105 2.60 X 105 実施例 1 4.10 X 104 4.40 X 10+ 5.60 X 103 3.02 X 104 比較例 1 7.80 X 106 6.10 X 106 6.71 X 106 6.87 X 106 [0093] [表 3] Initial number of bacteria 2.60 X 10 5 2.80 X 10 5 2.40 X 105 2.60 X 105 Example 1 4.10 X 10 4 4.40 X 10+ 5.60 X 10 3 3.02 X 10 4 Comparative example 1 7.80 X 10 6 6.10 X 106 6.71 X 10 6 6.87 X 106 [0093] [Table 3]
表 3  Table 3
Figure imgf000025_0001
Figure imgf000025_0001
[0094] 超音波洗浄後の抗菌評価 [0094] Antibacterial evaluation after ultrasonic cleaning
実施例 1および比較例 2で得られたフィルム状サンプルを 300mLの蒸留水に浸漬 し、超音波で 15分間洗浄した後、取り出して上記と同様の抗菌評価を行った。その 結果は下表 4の通りであり、抗菌性高分子水溶液に浸漬したのみの比較例 2で得ら れたフィルム状サンプルでは抗菌性が失われて菌の増殖が見られたのに対して、実 施例 1で得られたフィルム状サンプルは超音波洗浄後も十分な抗菌性を有すること が示された。  The film samples obtained in Example 1 and Comparative Example 2 were immersed in 300 mL of distilled water, washed with ultrasonic waves for 15 minutes, then taken out and subjected to the same antibacterial evaluation as described above. The results are shown in Table 4 below, whereas the film-like sample obtained in Comparative Example 2 that was only immersed in an antibacterial polymer aqueous solution lost its antibacterial properties and showed bacterial growth. The film-like sample obtained in Example 1 was shown to have sufficient antibacterial properties even after ultrasonic cleaning.
[0095] 比較例 2で得られたサンプルを 40°C、 16時間真空乾燥を行った後、 2gとり、蒸留 水中で超音波洗浄を 30分間行った後、 2 プロパノールに浸漬して 60°Cで 24時間 加熱した。抽出液からエバポレータを用いて溶媒を留去し、さらに真空ポンプで減圧 して完全に残存溶媒を除去して重量を測定したところ、抽出物は 0. 3mgであった。 また、溶媒をメタノール、エタノール、トルエン、へキサン、アセトン、メチルェチルケト ン、酢酸ェチル、酢酸ブチル、テトラヒドロフラン、ジメチルスルホキシドに変更して抽 出を行ったが、いずれもサンプルの乾燥重量の 0. 1重量%以上の抽出物が抽出さ れることはなかった。  [0095] The sample obtained in Comparative Example 2 was vacuum-dried at 40 ° C for 16 hours, then 2g was taken, ultrasonically washed in distilled water for 30 minutes, and then immersed in 2 propanol at 60 ° C. For 24 hours. When the solvent was distilled off from the extract using an evaporator and the pressure was reduced with a vacuum pump to completely remove the remaining solvent, and the weight was measured, the extract was 0.3 mg. In addition, extraction was carried out by changing the solvent to methanol, ethanol, toluene, hexane, acetone, methyl ethyl ketone, ethyl acetate, butyl acetate, tetrahydrofuran, or dimethyl sulfoxide, all of which were 0.1 weight of the dry weight of the sample. % Extract was not extracted.
[0096] [表 4] 表 4
Figure imgf000025_0002
実施例 5
[0096] [Table 4] Table 4
Figure imgf000025_0002
Example 5
ガラス板の代わりに透明樹脂(ポリ 4ーメチルペンテン 1)製のコンタクトレンズ用モ 一ルドを用いる以外は実施例 1と同様にして煮沸まで行い、コンタクトレンズ状サンプ ルを得た。 Contact lens module made of transparent resin (poly-4-methylpentene 1) instead of glass plate A contact lens sample was obtained by boiling until the boiling was performed in the same manner as in Example 1 except that a lould was used.

Claims

請求の範囲 The scope of the claims
[1] 分子内にアンモニゥム基を有するモノマー単位を有する高分子化合物 (A)が、ハイド 口ゲル (B)中に分散されてなることを特徴とする眼用レンズ。  [1] An ophthalmic lens comprising a polymer compound (A) having a monomer unit having an ammonium group in the molecule dispersed in a hydrated gel (B).
[2] 眼用レンズ中のアルコール性水酸基数を OH、アンモニゥム窒素の数を Nで表すとき[2] When the number of alcoholic hydroxyl groups in the ophthalmic lens is represented by OH and the number of ammonium nitrogen by N
、 N/OH比が 0. 001 -0. 5であることを特徴とする請求項 1記載の眼用レンズ。 The ophthalmic lens according to claim 1, wherein the N / OH ratio is 0.001 -0.5.
[3] 前記ハイド口ゲル (B)が、シリコーン成分を 20重量%以上含有するシリコーンノ、イド口 ゲルであることを特徴とする請求項 1または 2記載の眼用レンズ。 [3] The ophthalmic lens according to [1] or [2], wherein the hide mouth gel (B) is a silicone gel or id mouth gel containing 20% by weight or more of a silicone component.
[4] 前記ハイド口ゲル(B)中のシリコーン成分中のケィ素原子数のうち、 50%以上が極性 シリコーン成分のケィ素原子であることを特徴とする請求項 3記載の眼用レンズ。 [4] The ophthalmic lens according to [3], wherein 50% or more of the number of key atoms in the silicone component in the hide mouth gel (B) is a key atom of the polar silicone component.
[5] 前記極性シリコーン成分の極性基力、水酸基、アミド基、カルボキシル基、アミノ基、 カーボネート基、カーバメート基、スルホンアミド基、スルホン酸基、ホスホン酸基、メト キシェチル基、メトキシエトキシェチル基、ヒドロキシェチル基、ヒドロキシェトキシェチ ル基からなる群から選ばれた基であることを特徴とする請求項 4記載の眼用レンズ。 [5] Polar power of the polar silicone component, hydroxyl group, amide group, carboxyl group, amino group, carbonate group, carbamate group, sulfonamide group, sulfonic acid group, phosphonic acid group, methoxetyl group, methoxyethoxyethyl group 5. The ophthalmic lens according to claim 4, wherein the ophthalmic lens is a group selected from the group consisting of a hydroxyethyl group and a hydroxyethyl group.
[6] 前記シリコーン成分のうち、少なくとも 1種類が下記一般式 ω  [6] At least one of the silicone components is represented by the following general formula ω
M-L- Sx (a)  M-L- Sx (a)
で表されるシリコーンモノマーから得られる構造を有するものであることを特徴とする 請求項 3〜5のいずれかに記載の眼用レンズ。  The ophthalmic lens according to claim 3, wherein the ophthalmic lens has a structure obtained from a silicone monomer represented by the formula:
(Mはラジカル重合可能な重合性基を表す。 Lは炭素数 1〜20の置換されていてもよ い 2価の有機基を表す。 Aはシロキサニル基を表す。 )  (M represents a polymerizable group capable of radical polymerization. L represents an optionally substituted divalent organic group having 1 to 20 carbon atoms. A represents a siloxanyl group.)
[7] 前記式 (a)中の Lが下記一般式 (b)、 (c) [7] L in the above formula (a) is the following general formula (b), (c)
[化 1コ (CH2)j ( b ) [Chemical 1 (CH 2 ) j (b)
OH (CH2CHCH2)k— 0— (CH2)m— ( c ) のいずれかであることを特徴とする請求項 6記載の眼用レンズ。 7. The ophthalmic lens according to claim 6, which is any one of OH (CH 2 CHCH 2 ) k — 0— (CH 2 ) m — (c).
(jは 1〜20の整数を表す。 kは 1〜6の整数を表し、 mは 1〜; 17の整数を表す。ただし (j represents an integer of 1 to 20, k represents an integer of 1 to 6, m represents an integer of 1 to 17;
、 3k+m≤20である。) 前記式 (a)中の Lが一般式 (c)で表される基であることを特徴とする請求項 7記載の 眼用レンズ。 3k + m≤20. ) The ophthalmic lens according to claim 7, wherein L in the formula (a) is a group represented by the general formula (c).
前記シリコーンモノマーのうち、少なくとも一種類が下記式 (d)、(e)および (g)  Among the silicone monomers, at least one of the following formulas (d), (e) and (g)
[化 2]  [Chemical 2]
Figure imgf000028_0001
力、らなる群力 選ばれたモノマーであることを特徴とする請求項 6記載の眼用レンズ。
Figure imgf000028_0001
The ophthalmic lens according to claim 6, wherein the monomer is a selected group force.
(式(g)中、 Rは炭素数 1〜20のアルキル基または炭素数 6〜20のァリール基を表す(In the formula (g), R represents an alkyl group having 1 to 20 carbon atoms or an aryl group having 6 to 20 carbon atoms.
。 nは;!〜 20の整数を表す。 ) . n represents an integer of !!-20. )
[10] 前記シリコーンモノマーのうち、少なくとも 1種類が式(e)および(g)からなる群から選 ばれたシリコーンモノマーであることを特徴とする請求項 9記載の眼用レンズ。 10. The ophthalmic lens according to claim 9, wherein at least one of the silicone monomers is a silicone monomer selected from the group consisting of formulas (e) and (g).
[11] 前記高分子化合物 (A)の含有量が 0. 0:!〜 20重量%であることを特徴とする請求項[11] The content of the polymer compound (A) is 0.0 :! to 20% by weight.
;!〜 10の!/、ずれかに記載の眼用レンズ。 ! ~ 10! /, Ophthalmic lens according to any of the above.
[12] 前記アンモニゥム基を有するモノマーが下記一般式 (f ) [12] The monomer having an ammonium group is represented by the following general formula (f):
[化 3]
Figure imgf000029_0001
で表されることを特徴とする請求項 1〜; 1 1のいずれかに記載の眼用レンズ。 (R1は炭 素数 1〜30の置換されていてもよいアルキル基を表す。 R2〜R7は炭素数 1〜20の 置換されてレ、てもよ!/、アルキル基または炭素数 6〜20の置換されて!/、てもよ!/、ァリー ル基を表す。 R2と は環を形成していてもよい。 X—は任意のァニオンを表す。 ) [13] 高分子化合物 (A)と混合した状態で、ハイド口ゲル (B)のモノマーまたはマクロモノマ 一を重合させて得られることを特徴とする請求項 1〜; 12のいずれかに記載の眼用レ ンズ。
[Chemical 3]
Figure imgf000029_0001
The ophthalmic lens according to claim 1, wherein the ophthalmic lens is represented by: (R 1 represents an optionally substituted alkyl group having 1 to 30 carbon atoms. R 2 to R 7 may be substituted with 1 to 20 carbon atoms! /, An alkyl group or 6 carbon atoms. Substituent of ~ 20! Or may be! / Represents an aryl group, R 2 may form a ring, X— represents an arbitrary anion)) [13] Polymer compound 13. The ophthalmic lens according to claim 1, wherein the ophthalmic lens is obtained by polymerizing the monomer or macromonomer of the hide-mouth gel (B) in a state of being mixed with (A).
[14] 眼用レンズがコンタクトレンズであることを特徴とする請求項 1〜; 13のいずれかに記 載の眼用レンズ。  [14] The ophthalmic lens according to any one of [1] to [13], wherein the ophthalmic lens is a contact lens.
PCT/JP2007/068831 2006-09-29 2007-09-27 Ocular lens WO2008038721A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006-266708 2006-09-29
JP2006266708A JP4899757B2 (en) 2006-09-29 2006-09-29 Ophthalmic lens

Publications (1)

Publication Number Publication Date
WO2008038721A1 true WO2008038721A1 (en) 2008-04-03

Family

ID=39230156

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/068831 WO2008038721A1 (en) 2006-09-29 2007-09-27 Ocular lens

Country Status (2)

Country Link
JP (1) JP4899757B2 (en)
WO (1) WO2008038721A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010148772A (en) * 2008-12-26 2010-07-08 Toray Ind Inc Medical material
JP2010148776A (en) * 2008-12-26 2010-07-08 Toray Ind Inc Medical material
WO2011004808A1 (en) * 2009-07-08 2011-01-13 株式会社メニコン Ophthalmic lens
EP3745998A4 (en) * 2018-01-31 2021-09-01 KeraMed, Inc. Antimicrobial polymer for use in ophthalmic implants
CN116768554A (en) * 2023-05-04 2023-09-19 盐城市福奇混凝土有限公司 Superfine mineral admixture self-compacting high-performance concrete and preparation method thereof

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652499B2 (en) 2008-03-10 2014-02-18 Toray Industries, Inc. Medical antimicrobial composition and medical device comprising the same
JP5332569B2 (en) * 2008-09-10 2013-11-06 東レ株式会社 Medical materials
JP5563277B2 (en) * 2009-10-30 2014-07-30 株式会社シード Hydrous ophthalmic lens
JP5786851B2 (en) * 2010-03-02 2015-09-30 東レ株式会社 SKIN MATERIAL AND METHOD FOR PRODUCING SKIN MATERIAL
EP2745854B1 (en) * 2011-08-17 2018-02-07 Toray Industries, Inc. Medical device, and method for producing same
TWI496838B (en) * 2012-11-30 2015-08-21 Pegavision Corp Silicone hydrogel composition and silicone hydrogel contact lenses made of the composition
JP5452756B1 (en) * 2013-07-02 2014-03-26 Hoya株式会社 Method for producing silicone-containing copolymer molded article having hydrophilic surface and silicone hydrogel contact lens having hydrophilic surface

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06256421A (en) * 1993-02-09 1994-09-13 Ciba Geigy Ag Antifungal polymer containing quaternary ammonium group, composition thereof, and monomer used for producing same
JPH08510340A (en) * 1993-05-06 1996-10-29 アラーガン、インコーポレイテッド Antimicrobial lens and lens management system
JP2000162556A (en) * 1998-09-21 2000-06-16 Menicon Co Ltd Ocular lens material and its production
JP2001220394A (en) * 2000-02-07 2001-08-14 Toray Ind Inc Monomer, polymer and lens for eye
JP2001527141A (en) * 1997-12-29 2001-12-25 ボシュ・アンド・ロム・インコーポレイテッド Silicone-containing propolymer and low water content material
WO2005005517A2 (en) * 2003-06-30 2005-01-20 Johnson & Johnson Vision Care, Inc. Silicone hydrogels having consistent concentrations of multi-functional polysiloxanes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2774233B2 (en) * 1992-08-26 1998-07-09 株式会社メニコン Ophthalmic lens materials
BR9814012A (en) * 1997-11-12 2000-09-26 Bausch & Lomb Disinfection of contact lenses with polyquaterniums and polymeric biguanides.
US8425926B2 (en) * 2003-07-16 2013-04-23 Yongxing Qiu Antimicrobial medical devices

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06256421A (en) * 1993-02-09 1994-09-13 Ciba Geigy Ag Antifungal polymer containing quaternary ammonium group, composition thereof, and monomer used for producing same
JPH08510340A (en) * 1993-05-06 1996-10-29 アラーガン、インコーポレイテッド Antimicrobial lens and lens management system
JP2001527141A (en) * 1997-12-29 2001-12-25 ボシュ・アンド・ロム・インコーポレイテッド Silicone-containing propolymer and low water content material
JP2000162556A (en) * 1998-09-21 2000-06-16 Menicon Co Ltd Ocular lens material and its production
JP2001220394A (en) * 2000-02-07 2001-08-14 Toray Ind Inc Monomer, polymer and lens for eye
WO2005005517A2 (en) * 2003-06-30 2005-01-20 Johnson & Johnson Vision Care, Inc. Silicone hydrogels having consistent concentrations of multi-functional polysiloxanes

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010148772A (en) * 2008-12-26 2010-07-08 Toray Ind Inc Medical material
JP2010148776A (en) * 2008-12-26 2010-07-08 Toray Ind Inc Medical material
WO2011004808A1 (en) * 2009-07-08 2011-01-13 株式会社メニコン Ophthalmic lens
US9017716B2 (en) 2009-07-08 2015-04-28 Menicon Co., Ltd. Ophthalmic lens
JP5766603B2 (en) * 2009-07-08 2015-08-19 株式会社メニコン Ophthalmic lens
EP3745998A4 (en) * 2018-01-31 2021-09-01 KeraMed, Inc. Antimicrobial polymer for use in ophthalmic implants
EP3850018A4 (en) * 2018-01-31 2021-11-17 Keramed, Inc. Antimicrobial contact lenses
CN116768554A (en) * 2023-05-04 2023-09-19 盐城市福奇混凝土有限公司 Superfine mineral admixture self-compacting high-performance concrete and preparation method thereof
CN116768554B (en) * 2023-05-04 2024-06-07 盐城市福奇混凝土有限公司 Superfine mineral admixture self-compacting high-performance concrete and preparation method thereof

Also Published As

Publication number Publication date
JP2008083649A (en) 2008-04-10
JP4899757B2 (en) 2012-03-21

Similar Documents

Publication Publication Date Title
JP5600863B2 (en) Silicone polymers, ophthalmic lenses and contact lenses
WO2008038721A1 (en) Ocular lens
AU2002236279B2 (en) Monomer, polymer, and ocular lens and contact lens each obtained therefrom
JP5633147B2 (en) Antibacterial composition for medical use and medical device
AU2001288111B2 (en) Polymer and ocular lens comprising the same
RU2682256C2 (en) Silicone acrylamide copolymer
JP2007186709A (en) Monomer for ophthalmic lens, polymer for ophthalmic lens, and contact lens
JP2001323024A (en) Monomer, polymer and ophthalmic lens using the same
WO2002081532A1 (en) Monomers, polymers, and ophthalmic lenses and contact lenses made by using the same
JP5076256B2 (en) Monomer composition, polymer and ophthalmic lens using the same
AU2015241171A1 (en) Silicone acrylamide copolymer
JP5332569B2 (en) Medical materials
JP4123648B2 (en) Polymer and ophthalmic lens using the same
JP2000191730A (en) Monomer for ophthalmic lens, polymer for ophthalmic lens and contact lens using the same
JP5352983B2 (en) Ophthalmic lens
JP2009204770A (en) Ophthalmic lens
JP2002128829A (en) Monomer, polymer, and ophthalmic lens using the same
JP4859004B2 (en) Polymers and contact lenses for contact lenses, intraocular lenses or artificial corneas
JP2010032992A (en) Ophthalmic lens
JP4058977B2 (en) Polymer, ophthalmic lens and contact lens using the same
JP5900424B2 (en) Ophthalmic lens
JP2001323026A (en) Monomer, polymer and ophthalmic lens
JP2001323025A (en) Monomer, polymer and ophthalmic lens using the same
JP2002371116A (en) Monomer, polymer, ocular lens and contact lens each using the polymer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07828577

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07828577

Country of ref document: EP

Kind code of ref document: A1